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Abstract 
 
Background 
The majority of patients requiring mechanical ventilation are over the age of 65 and 
advanced age is known to increase the severity of ventilator-induced lung injury (VILI) 
and mortality.  However, the mechanisms which predispose aging ventilator patients to 
increased mortality rates are not fully understood.   
 Pulmonary edema is a hallmark of VILI and the severity of edema increases with 
age.  Ventilation with conservative fluid management decreases mortality rates in acute 
respiratory distress (ARDS) patients, but has not been investigated in VILI.  We 
hypothesized that age-associated increases in pulmonary edema promote age-related 
increases in ventilator-associated mortality.  Endoplasmic reticulum (ER) stress can 
disrupt cellular functions and plays a key role in many disease states.  The severity of 
ER stress also increases with age.  We hypothesized that age-associated increases in 
ER stress also increase in the severity of VILI. 
 Finally, serum Vitamin C (VitC) levels also decrease with age.  VitC treatments 
have been shown to decrease mortality rates in murine models of ARDS by and 
attenuate pulmonary edema.  We hypothesize that VitC treatments will attenuate 
ventilator induced pulmonary edema in our aged murine subjects.  
Methods 
Mechanical Ventilation:  Young and old mice were mechanically ventilated with either 
high tidal volume (HVT) or low tidal volume (LVT) for with either liberal or conservative 
fluid support.  One group received VitC treatment prior to ventilation.   
   
xiii  
Cell Stretch:  Alveolar epithelial cells (ATIIs) from young and old mice were harvested, 
cultured, and mechanically stretched.  Treatment groups received ER stress inhibitor 4-
PBA.      
Results 
Both advanced age and HVT ventilation significantly increased inflammation, injury, and 
decreased survival rates.  Conservative fluid support significantly diminished pulmonary 
edema decreased mortality rates.  VitC treatments significantly decreased pulmonary 
edema and improved pulmonary mechanics.  Mechanical stretch promoted ER Stress 
and upregulated proinflammatory gene expression and secretion in aged ATIIs.  ER 
stress inhibition attenuated all of these effects.  
Conclusion 
Conservative fluid management alone attenuated age-associated increases in 
ventilator-associated mortality.  VitC treatments decreased pulmonary edema and 
partially restore pulmonary mechanics in old mice ventilated with HVT.  ER stress 
inhibition decreased stretch induced proinflammatory gene expression and protein 
secretion in aged mechanically stretched ATII cells.  
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CHAPTER 1  INTRODUCTION 
 
1.1.0 Lung Anatomy and Physiology 
In humans the chief function of the lungs is to facilitate the exchange of carbon dioxide 
and oxygen between our blood stream and the atmosphere.   In addition to respiration 
the lungs perform numerous other important biological functions which include providing 
the expiration of air needed for phonation, extra buoyancy when we are immersed in 
water, a supplemental method of thermoregulation, and the lungs mucosal layer and 
leukocytes act as an important second line of defense against inhaled infectious agents 
and other harmful environmental factors1,2. 
 
1.1.1 Generations of the Lung 
The physical pathway through which air moves is known as the respiratory tract.  The 
respiratory tract begins as a single airway but as it moves distally it divides.  Every 
division is roughly a bifurcation and each is ascendingly enumerated as generation 
(figure 1). 
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Figure 1: Diagram of the divisions of the respiratory tract.  Reprinted from McNulty et al3. 
 
The first 16 generations (divisions 0 through 15) of the respiratory tract are called 
the conduction zone and include the nose, pharynx, larynx, trachea, bronchi, 
bronchioles, and terminal bronchioles.  Because each generation of divisions roughly 
doubles the number of pathways in the respiratory tract the final generation of the 
conduction zone has approximately 32,270 pathways or roughly 2^15.  The primary 
function of the conducting zone is to act as a passageway through which air is able to 
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reach the rest of the respiratory tract.  In addition the conduction zone filters, heats, and 
humidifies the inhaled air all of which aid in respiration.  The conduction zone is also the 
site of phonation1,4.   
Additionally, the conduction zone acts as the body's first line of defense against 
inhaled pathogens and harmful environmental factors.  The epithelium of the conducting 
airways contains goblet cells which secrete high molecular weight mucus glycoproteins 
which entrap inhaled irritants, particles and micro-organisms.  These same epithelium 
are also lined with motile cilia which function to move the entrapped material up and out 
of the respiratory tract1,5–7 
 
Figure 2: Respiratory Bronchioles transition from a terminal bronchiole, to respiratory bronchioles, to alveolar ducts, which terminate in alveolar sacs and individual alveoli. Reprinted from Kerr et al8.   
The remaining nine generations (divisions 16 through 24) of the respiratory tract 
are known as the respiratory zone and contain the respiratory bronchioles, alveolar 
ducts, alveolar sacs, and the individual alveoli (figure 2).  As its name suggest the 
respiratory zone is the region in which all of the respiration takes place.  The functional 
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biological units of respiration are small space filled fluid lined sacs called alveoli (figure 
3) through which carbon dioxide and oxygen are exchanged with the bloodstream1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Alveolus Diagram.  Reprinted from public domain9 
 
As the bronchioles go through successive generations of division eventually 
around their 6th generation (the 17th generation of the respiratory tract overall) they 
begin to express individual alveoli as outgrowths.  With each successive generation, the 
number of individual alveolar outgrowths increases.   
 This continues as the respiratory bronchioles eventually divide into the alveolar 
ducts which are heavily lined with alveoli.  Each alveolar duct terminates with 2-3 large 
clusters of alveoli called an alveolar sac.  The terminal ends of the alveolar ducts occur 
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at the 23rd division which means that there are roughly 16.8 - 25.2 million alveolar sacs 
in the adult lungs.   
Each sac contains roughly 20 alveoli which mean that there are roughly 350-500 
million alveoli in each pair of adult human lungs.  The alveolar sacs contain the largest 
concentration of alveoli in the body.  The individual alveoli on the respiratory bronchioles 
and the alveolar ducts are responsible for roughly 10% of the gas exchanged during 
respiration and the alveoli contained in alveolar sacs are responsible for the remaining 
90%1,5,10.   
 
1.1.2 Alveolar Structure and Function 
In total the alveolar walls, or interalveolar septa, account for 99% of the interior surface 
area of the lungs which in adult humans is about 100 to 150 square meters.  The alveoli 
share these septa among neighboring alveoli which makes it impossible to make an 
exact distinction between the individual alveoli.  When a 2D section of lung parenchyma 
is viewed it closely resembles dense foam with the major difference being that the 
alveolar sacs eventually open to alveolar ducts which interconnect and lead back up the 
respiratory tract1,2,5.  The alveoli have two kinds of openings in addition to the main 
opening to the alveolar duct.   
 The first type of openings are called pores of Kohn and serve to interconnect 
neighboring alveoli.  The second type of openings are called canals of Lambert and 
connect the alveoli to the terminal respiratory bronchioles.  Both of these openings have 
the same basic function which is that they allow air to pass collaterally between the 
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alveoli and bronchioles.  This creates an interdependence in the alveolar air pressure 
which helps to stabilize them and helps air to reach underinflated alveolus1 
 
1.1.3 Alveolar Epithelial Cells 
The alveolar septa are covered with two morphologically distinct types of pneumocyte 
cells.  
 
Figure 4: Diagram of the alveolar epithelium. Reprinted from Antranik et al14. 
 ATI pneumocytes (ATIs) are squamous epithelial cells which means that they are flat, 
stretched out, and create a tile like cell layer. They cover both the inner and outer 
surface of the alveolar septa (figure 4).  ATI cells are also relatively large (diameter of ∼ 
50 to 100 μm and volume of ∼ 2,000 to 3,000 μm3).  ATII pneumocytes are cuboidal 
epithelial cells.  They exist only on the interior surface of the alveolar septa and protrude 
into the interior space of the alveolar sacs.  They are relatively small compared to the 
   
7  
ATI cells (diameter ∼ 10 μm and volume of ∼ 450 to 900 μm3).  Even though ATI cells 
comprise only 8% of the cells found in the alveolar region, because of their larger size 
and their extremely stretched flattened arrangement they cover 95% of the alveolar 
surface, the rest being covered by the ATII cells7,15.   
 It has long been assumed that since ATI cells form the surface across which 
essentially all of the gas is exchanged during respiration that they have significant 
functionality with regards to facilitating this process.  However, the physiological role of 
ATI cells in respiration is still yet to be fully elucidated.  Despite this shortcoming our 
understanding of their role in innate host defense and in alveolar fluid clearance has 
developed considerably in the recent past.  The Na+ gradient that drives fluid absorption 
across the alveolar epithelial barrier is created by active transport through the Na-K-
ATPase pump, the 1a and 1b subunits of which are the most common Na pump 
subunits in alveolar epithelial cells.  In one study a cell specific deletion of the 1b 
subunits in ATI’s created a significant decrease in alveolar fluid clearance16.  However, 
this knockout did not lead to increased pulmonary edema in either hyperoxia induced or 
ventilator induced lung injury models relative to similarly injured wild type controls. 
 Thus while ATIs involvement in alveolar fluid clearance is clear their exact role is 
yet to be fully elucidated.  Additionally, it has recently been discovered that the 
inflammatory response of ATI cells to inflammation and injury is more acute than that of 
ATIIs17.  In one study, relative to similarly cultured ATIIs, isolated ATI’s were shown to 
exhibit both a higher level of inflammatory gene expression in control groups, when 
treated with LPS, when cocultured with alveolar macrophages, and when cultured with 
treated media from LPS treated macrophages18.   
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 It is also known that ATI cells are generally unable to proliferate15 which leads to 
one of the two primary functions of ATIIs.  ATII cells are responsible for mediating all 
primary replenishment of injured or dead alveolar epithelial cells.  When either ATI or 
ATII cells die and are sloughed off they leave a nude section of the basement 
membrane.  When this occurs resident ATII cells divide and repopulate the area.  They 
then either remain as ATII cells or transdifferentiate into an ATI cells depending on 
which cell type they are replacing15. 
 The second primary function of ATII cells is to synthesize surfactant, store it in 
vesicles called lamellar bodies, as secrete it as needed into the alveolus.  Surfactant 
serves the important job of decreasing the surface tension on the inside of the alveoli.19  
The insides of the alveoli are coated with water, the molecules of which form hydrogen 
bonds with one another.  Below the surface water molecules are surrounded on all 
sides by other molecules so the forces are in equilibrium.  However, at the air liquid 
interface the forces are unbalanced which causes surface molecules to attach more 
strongly to each other than to the air.  This gives rise to a surface tension the result of 
which is that the water molecules on the interior of the alveoli are highly attracted to 
each other.  This has the effect of creating a contractile force which both attempts to 
collapse the alveoli and makes it more difficult to open them(figure 5).  The surfactant 
produced by the ATII cells counteracts this surface tension y laying on the surface of the 
water and interrupting the hydrogen bonds7,15,20.  
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any surfactant present would be such that unassisted inflation of the lungs would not be 
possible.  The Second important function of the surfactant is to stabilize the air flow 
between neighboring alveoli.  According to the law of Laplace the collapse pressure on 
a sphere is inversely proportional to its radius (figure 5A).  This means that the pressure 
needed to collapse a smaller alveolus is much less than the pressure required to 
collapse a larger one.  And since the alveoli collaterally linked through several openings, 
this means that normally if one alveolus were less inflated than a neighbor to which it 
was attached, all of the air would naturally flow out of the smaller alveolus into the larger 
one and the smaller alveolus would totally collapse1,17 
The reason why this does not in general happen is because the surfactant 
decreases the surface tension more on the less inflated alveoli than on the more inflated 
ones.  This is simply a result of the fact that the smaller alveolus has the same amount 
of surfactant as the larger alveolus but a smaller interior surface over which the 
surfactant is spread (figure 5B).  And with a more surfactant units per area on the 
surface, the surface tension of the alveolus is more completely disrupted.  The net result 
is that that the collapsing pressure for the alveoli is essentially independent of their 
inflation which means that they are stabilized with regards to one another2,17. 
 
1.1.4 Alveolar Basal Membrane, ECM, and MACs 
Directly beneath the ATI and ATII cells both on the interior and exterior of the alveoli is 
the alveolar basement membrane.  Inside of the basement membrane is an interstitial 
space.  Contained in this interstitial space are several very important cell types and 
structures.  Of primary importance are the abundant capillaries that fill this space.  
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These capillaries have an outer covering that consists of a thin basement membrane.  
Directly inside of this basement membrane is a single cell thick endothelial layer of 
squamous cells which create the capillary wall.  Inside of these capillaries are a 
constant flow of erythrocytes and plasma18 
Figure 6:  Alveolar epithelial barrier histology. Reprinted from Kerr et al8. 
 
As the alveoli are ventilated oxygen passes from the open space of the alveolar 
sac into the alveolar septa then through the ATI cells then through the alveolar 
basement membrane.  Once inside the septal wall the oxygen passes through the 
interstitia, then through the capillary basement membrane, then through the outer 
membrane of the endothelial cells, then through the cytoplasm, then through the inner 
membrane into the plasma of the capillary and finally into the erythrocytes themselves.  
And carbon dioxide traverses the same path in the opposite direction5,21.  Because the 
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gas exchange that takes place during respiration is passive it is extremely important that 
the distance that the gasses traverse be as short as possible (figure 6).   
There are several physiological adaptations of the capillary endothelia that help 
to facilitate this.  The endothelial cells have fewer organelles than other similar 
endothelial cells which allow the capillary wall to be stretched particularly thin across 
certain areas.  Those organelles that they do have are gathered closely to the nucleus 
which is itself usually organized axially with the septal wall and or towards the junctions 
between ATI cells.  This means that while the cells are thick in the regions around the 
nucleus they are able to remain very thin for most of their surface that is oriented 
towards the ATI cells of the alveolar septa.  This thin region of the endothelium that lies 
parallel with the alveolar septa is additionally thinned by the fusing of the outer 
endothelial membrane with the capillary basement membrane.  The result is that on the 
face of the endothelium oriented towards the alveolar septa the entire capillary 
endothelium is composed of two thin membranes with a tiny amount of intercalated 
cytoplasm that’s width totals only 20nm.  At some places the entire barrier between the 
alveolar air and the blood stream is only 200nm (figure 7).   
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Figure 7:  (left) Alveolar capillary lined by endothelial cell.  (right) Two cell air blood alveolar barrier.  Reprinted from Wiebel et al18. 
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Figure 8: Collagen and Elastin fiber networks surrounding alveolar epithelium.  Reprinted from Toshima et al20.   
Additionally in this interstitial space there are fibroblasts that manufacture 
collagen and elastin fibers.  These fibers form bundles that create a collagen and elastin 
network that extend from the large airways down to the alveoli and make up the basis 
for the physical structure of the septal walls and the lung parenchyma itself (figure 8).  
These fibers form dense rings around the alveolar entrances and in the case of elastin 
they are interconnected with the elastin networks of the blood vessels.  These fiber 
networks are responsible for a major component of the lungs mechanical behavior 
which we will discuss shortly5–7,21.   
Finally, patrolling the interior space of the alveolar septa are alveolar 
macrophages that migrate around and phagocytose cellular debris, foreign cells, and 
other harmful pathogens (figure 9).  Collectively the lung parenchyma are comprised of 
the bronchioles, bronchi, blood vessels, alveolar ducts, alveolar sacs, individual alveoli, 
and interstitial cells and structures7,22 
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Figure 9: Alveolar Macrophage Attacking E Coli Bacteria.  Image copyright Dennis Kunkel Microscopy, Inc23.  
 
1.2 Pulmonary Mechanics 
Normal respiration requires that the respiratory zone be continually ventilated, a process 
consisting of cycles of the inspiration and subsequent expiration of air.  The body 
achieves ventilation of the respiratory zone by physically changing the dimensions 
thoracic cavity in which the lungs reside.  The cavity itself is bounded by on the top and 
sides by the thoracic wall by the and by the diaphragm on the bottom.  The thoracic wall 
is comprised of a layer of interior and exterior intercostal muscles imbedded into which 
are the ribs.  The diaphragm is a thin musculotendinous dome shaped structure that 
separates the thoracic and abdominal cavities7,24 
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 Immediately surrounding the lungs is a serous membrane called the visceral 
pleura.  Opposed to it and lining the interior of thoracic wall and diaphragm is another 
serous membrane called the parietal pleura.  There is a thin fluid filled region in 
between them called the interpleural space.  Systemic circulation provides the parietal 
pleura with high-pressure blood which causes it to constantly secrete fluid into this 
space while the visceral pleura is constantly reabsorbing fluid from the space.  The 
interpleural space is of extreme importance to the normal function of the lungs because 
in addition to providing lubrication for the movement of the lungs in the thoracic cavity, 
the fluid provides an airtight seal that causes the two membranes to adhere to one 
another.  This means that any Increasing volume of the thoracic cavity itself also 
increases the volume of the lungs and therefore increases the volume of the respiratory 
tract.  This decreases the internal air pressure of the respiratory tract which in turn 
creates an inspiration of air.  A subsequent decrease in the volume of the thoracic cavity 
increases the pressure in respiratory tract and expires the air1.   
 Additionally the interpleural space is important because of the recoil pressure it 
applies to the lungs.  As we will discuss in more detail later, the elastic nature of the 
lungs causes them to have a constant recoil pressure.  Normally this would cause them 
to collapse, however since the interpleural space is air tight the recoil pressure of the 
lungs sets up a negative pressure in the interplural space which balances the recoil 
pressure of the lungs and keeps them from collapsing.  Because of this, any puncture to 
the interplural space that allows air to enter results in the collapse of one or both lungs. 
7,24 
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The expansion of the thoracic cavity is achieved by the contraction of the 
respiratory muscles.  During normal or ‘quiet’ breathing the principle muscle responsible 
for the expansion of the thoracic wall is the diaphragm with some help from the exterior 
intercostal muscles.  During quiet breathing the diaphragm contracts and distends 1-2 
cm downwards and the thoracic cavity is expanded while the contents of the abdominal 
cavity are compressed.  In more forceful breathing the expansion of the thoracic wall 
benefits from an increased contribution from a large group of accessory muscles 
distributed across in the thoracic, back, neck and abdomen.  Additionally during maxima 
breathing the diaphragm can distend up to 10 cm7,24.   
During cycles of normal ventilation the expiration ends while the airways still 
have a positive volume in order to prevent the collapse of the alveolar sacs.  We will 
discuss the importance of not collapsing the alveoli momentarily.  During a normal 
maximal inspiration the lungs volume increases approximately fourfold compared to its 
end expiratory minimum.  This means that the dimensions of the lung are expanding by 
roughly a factor of 4ଵ/ଷ = 1.6.  Most of this expansion occurs in the alveoli and alveolar 
ducts and is isotropic due to surface properties of the liquid on the alveoli and their 
collateral airflow24.  
During inspiration the parenchymal fibers go from being crimped to being 
straightened out (figure 10).  Additionally the septal walls begin the inspiration 
containing undulations or “crumples” which get smoothed out as the alveoli begin to 
inflate.  Because these fibers contain elastin, when they are stretched much of the 
energy used to stretch them is converted to mechanical potential energy instead of 
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being converted to heat.  This stored energy means that when lung tissue is expanded it 
develops contractile force.  This contractile force and the one created by the alveolar  
surface tension combine to create the lung's elastic recoil21,24.   
 
Figure 10: (left) Crumpled lung collagen ECM.  (right) Inflated lung collagen ECM. Reprinted from Toshima et al20. 
 
The elastic properties of lung tissue are generally referred to as compliance and 
are written as ܥ ൌ  ߂ܸ/߂ܲ where ߂ܸand ߂ܲ are change in lung volume and lung 
pressure respectively.  This equation means that compliance is defined as the 
reciprocal of elasticity.  Therefore to better understand the mechanical properties of the 
lungs it is important to determine the compliance of both healthy and diseased lungs at 
all of the pressures and volumes experienced during ventilation.  This is generally done 
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by ventilating a lung and measuring the pressure at the airway opening.  However, in 
order to use our equitation, we must modify it to account for two additional important 
mechanical factors.  Firstly, our equation must reflect the work that the lung does on the 
air as it circulates.  Secondly, the thoracic wall to which the lung is attached has elastic 
properties of its own which means that the recoil pressure it generates must be included 
in our equation as well.  When considering  these effects if we assume that the lungs 
have one degree of freedom (isotropic expansion) then the equations of motion 
become25: 
 
஺ܲை=V/C + V˙R + V¨I - ௧ܲ௛௢ 
 
Where ஺ܲை is the pressure at the airway opening, ௧ܲ௢௥ is the pressure generated thoracic 
walls elastic recoil, V is lung volume, V˙ is gas flow, R is airway resistance, V¨ is 
convective gas acceleration, I is impedance, and C is the previously mentioned 
compliance. 
 From this equation we can clearly see the advantages of examining the 
compliance of the lung using a model in which the lung is not in motion while 
measurements are being taken (static pressure-volume analysis).  Additionally because 
of the effect of the pressure exerted by the chest wall there is also merit to examination 
of a lung that has been excised from the thoracic cavity.  Furthermore as previously 
discussed both the collagen and elastin fibers and the surface tension of the alveoli 
contribute to the lungs elastic recoil.  Since the surface tension of the alveoli are 
dependent on their having an air liquid interface the effect of the alveolar surface 
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tension could be effectively removed by using an experimental model in which the lungs 
as ventilated with liquid instead of air.  This allows the recoil forces of the lung 
parenchyma to be studied independently.  Figure 11 contains the pressure volume 
loops of an excised cat lung ventilated with both air and saline.   
 
 
Figure 11: Pressure volume loops obtained from cat lung submerged in saline. Reprinted from Harris et al25 
 
Figure 11 contains two very important features.  The first is that the recoil 
pressures are greater at every volume in the air filled lung than in the saline filled lung.  
This means that the surface tension of the alveoli have a substantial effect on the 
amount of force needed to inflate the lungs.  One obvious implication of this effect is 
that liquid ventilation can achieve inspiration and expiration of the lung with the 
application of lower pulmonary pressure than conventional gas ventilation24,25. 
The second important feature of the graph is that there is a much greater 
separation between the inflation and deflation limbs of the air filled lung than the saline 
filled lung.  At any given volume the air filled lung has a much greater recoil pressure 
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during its inflation that its deflation.  Because the graph is of pressure versus 
displacement the difference in the two graphs represents the hysteresis of the lungs 
during ventilation.  Therefore this graph demonstrates that the majority of the hysteresis 
of the lungs during ventilation is due to the surface tension of the alveoli7,24,25. 
While giving us information about the role of alveolar surface tension, this model 
fails to investigate the relationship of the elastic recoil of the thoracic wall and that of the 
lungs.  In order to do investigate this we must first create an equation that relates the 
compliance of the lungs and that of the thoracic wall independently and in combination.  
If we treat the thoracic wall and the lungs like two elements in series the equation for the 
compliance of the combined system is equal to the sum of the reciprocal of the two 
elements individually or: 
 
1/ܥோௌ = 1/ܥ௅ + 1/ܥ்ௐ 
 
Where ܥ்ௐ is the compliance of the thoracic wall, ܥ௅is the compliance of the lungs, and 
ܥோௌ is the compliance of the combined respiratory system.  ܥ௅ and ܥ்ௐ can then be 
calculated independently.  At pressures controlled through mechanical ventilation the 
changes in the volume of the wall can be directly observed as the distention of the 
diaphragm is inferred from of the movement of the abdomen.  
When the ܥ௅, the ܥ்ௐ, and the resultant ܥோௌ values are measured, calculated, 
and graphed respectively for an adult human we get the graph in figure 12 as a result.  
TLC is total lung capacity, FRC is function reserve volume (the volume of air remaining 
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in the lungs after normal exhalation) and RV is residual volume(the volume of air in the 
lungs after maximal exhalation)7,24,25.   
The graph in figure 12 has several important features.  Firstly when we look at 
the graph of the lung compliance we see that at its minimum volume its pressure and 
volume never go to zero.  Additionally as its volume increases its compliance has a 
relatively linear region then drops off sharply.  This is the type of behavior we would 
expect to see in biological tissue whose elastic properties come from elastin and 
collagen fibers since we know that they have a tendency to behave in a linearly elastic 
fashion until they are fully stretched out then have a sharp drop off in compliance.  
Secondly when we observe the thoracic wall graph we see that it has no elastic recoil 
pressure when its volume is equal to around 4L (figure 12).  When its volume is less 
than 4L it has a negative recoil pressure which means it attempts to expand.  
Additionally because the thoracic wall’s compliance decreases with decreasing volume, 
the amount of pressure needed to continue to decrease its volume continues to 
increase.  When we analyze the combined graph we soon see why this is important. 
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Figure 12: PV graph of combined chest and lung wall mechanics. Reprinted from Harris et al25 
 
 The net effect of the combination of the two graphs is that at low volumes the 
negative elastic recoil pressure of the thoracic cavity dominates the compliance of the 
system.  This is beneficial because for all volumes lower than the FRC the recoil 
pressure on the lungs attempts to inflate them.  This means that inflating the lungs from 
any volume below the FRC to the FRC takes no energy which helps to maintain the 
residual lung volume needed to prevent the alveoli from collapsing.  And at larger 
volumes the elastic recoil of the lungs dominates the system which is beneficial 
because it both allows the mechanical energy of inspiration to be stored physically in 
the arrangement of the fibers so that expiration requires less energy, and it prevents the 
over inflation of the lungs and alveoli7,24,25.  
 In order to determine if there are any other mechanical benefits to the function of 
the lungs during respiration contributed by the elastic properties of the lungs  we can 
observe the pressure-volume graphs for experiments in which the lungs are made to 
   
24  
inflate at pressures below the FRC.  In this experiment cats were ventilated using a 
negative pressure ventilators beginning at pressures both above and below their FRC 
(figure 13).  The most important features of this graph are that while the pressure-
volume curve for the expirations seems to be independent of the starting volume, the 
curve of the inspiration is shifted downwards when the lungs are inflated from below the 
FRC.  This means that it requires more energy and more energy is lost when the lungs 
inspiration begins below the FRC. 
 
Figure 13: Graph of lung inflation below FRC. Reprinted from Harris et al25.  
 
We can also note that this graph (figure 13) has a much lower hysteresis than the one 
we observed previously in the air ventilated cat lung.  This seeming disagreement can 
be resolved by replicating this experiment with an excised lung7,24,25.  
 Here we see a similar set of pressure-volume curves when the initial volume for 
this extracted of lung is close FRC for the intact lung.  However, we see that if we allow 
the lungs initial volume to go to zero and the lungs and alveoli to completely collapse we 
get a graph that matches our first experimental graph of the excised cat lung.  From this 
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was can clearly see that the amount of energy list to hysteresis when the lungs are 
allowed to fully collapse is significantly larger than the amount of energy lost to during 
normal ventilation25. 
 
1.3.0 Ventilator Induced Lung Injury and Pulmonary Edema 
Many pathophysiological states can result in a person’s inability to adequately ventilate 
their lungs with spontaneous breathing which makes mechanical ventilation a necessary 
and potentially lifesaving clinical intervention.  These pathological states include Acute 
Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Asthma, 
and Chronic Obstructive Pulmonary Disease (COPD)26–28.  It is estimated that annually 
there are 800 thousand hospitalizations in the United States requiring mechanical 
ventilation with an estimated in-hospital mortality rate of 34.5%.  This represents 2.7 
episodes of mechanical ventilation and .9 deaths per 1000 individuals in the U.S.  This 
means that pathological conditions requiring mechanical ventilation lead to more deaths 
annually than breast cancer and prostate cancer combined.  The national costs of 
mechanical ventilation are estimated at $27 billion dollars per year and account for 12% 
of all hospital costs in the United States29. 
 
1.3.1 Impact of VILI 
Despite its necessity as a potentially life-saving clinical intervention, mechanical 
ventilation (MV) can result in ventilator induced lung injury (VILI).  The three proposed 
mechanisms of VILI are over-distention of the alveoli (volutrauma), cyclic recruitment 
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and derecruitment of the alveoli (atelectatrauma), and secondary injury caused by the 
stretch or injury-induced release of inflammatory cytokines (biotrauma) 27,30(figure 14).   
 
 
Figure 14: Flow chart of the mechanisms of VILI. Reprinted from Carrasco et al31  
 The largest population of patients requiring MV is the elderly29, and age is a 
known predictor for the severity of VILI32.  As people age the chest wall becomes less 
compliant, the lung parenchyma loses elasticity, the average alveolar diameter 
increases, and overall lung capacity diminishes 10,33.  Additionally over time the lungs 
capacity to recover from injury diminishes and its inflammatory responses increase34.  
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These physiological changes in the aging lung correlate to each of the proposed 
mechanisms of VILI.  Accordingly age is a predictive factor in the severity of VILI; 
however, the exact relationship between age and the severity of VILI is currently 
unknown.  The increase in the severity of VILI with patient age combined with the 
increased need for ventilation and mortality rate among the elderly makes the 
investigation of this relationship even more important. 
 A consistent feature in all of the proposed mechanisms of injury is that they occur 
at the level of the alveoli27 (figure 15).  This would seem to suggest that there is a 
meaningful substantive difference between the physiological and mechanical behaviors 
of healthy lung alveoli under spontaneous breathing and in alveoli being injuriously 
mechanically ventilated.  It would also seem to suggest that there are age related 
changes in these physiological and mechanical behaviors that play an important role in 
the severity of VILI. 
 
Figure 15: Diagram of the alveolar mechanisms of VILI.  Reprinted from Reynaud et al30   
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1.3.2 Biotrauma 
Both through mechanotransduction and cell/tissue injury, MV has been shown to up-
regulate the production and excretion of inflammatory cytokines in the lung, which in 
turn can further aggravate lung injury.  Stress failure of the alveolar barrier 
(decompartimentalisation) and stress failure of the plasma membrane (necrosis) have 
been shown to release cytokines into the lung as well as into systemic circulation 35. 
Mechanotransduction is also sufficient to cause the release of cytokines into the lung.  
In one study, Bronco alveolar lavage fluid (BALF) concentrations of TNF-a and 
interleukin (IL) 6 were elevated in infants without prior lung injury who were treated with 
MV for whom no clinically obvious harmful effects of MV were observed 36. 
 In addition to the release of cytokines, biotrauma is an upstream regulator for the 
recruitment and extravasation of leucocytes in the lung37,38.  The biotrauma associated 
with adult acute lung injury and neonatal chronic lung disease has also been shown to 
delay leucocyte apoptosis 39,40and cause apoptosis of pulmonary epithelial cells. 
 Not surprisingly the immune and inflammatory response by to injurious 
mechanics stretch is not localized to the lungs41.  The majority of patients who die from 
acute respiratory distress (ARDS) die from multiple organ dysfunction syndrome 
(MODS)41.  Concentration differences across the lung (difference between arterial and 
mixed venous) of inflammatory mediators have been detected in patients with ALI with 
ARDS42,43, indicating a significant release of these pro-inflammatory molecules by lung 
tissue.  In one study, rabbits treated with injurious MV showed significantly increased 
renal apoptosis, renal dysfunction, and small intestine apoptosis compared to rabbits 
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receiving a protective ventilation strategy44.  An ARDS network study has also shown 
that after three days with of either high or low tidal volume MVs, patients with low tidal 
volumes have lower serum level of IL-6,  increased organ failure-free days, and lower 
mortality than those with high tidal volume ventilation45,46.  Understanding the 
mechanisms of VILI-associated biotrauma could prove critical for increasing survival in 
ventilated patients.   
 A direct investigation of the of the effect that age has on the lungs immune and 
inflammatory response to mechanical stretch and ventilation can be  accomplished in a 
relatively straightforward manner using scientific methods currently in use.  The alveolar 
epithelial cells of young and elderly mice can be harvested, grown in culture, and 
exposed to cyclic mechanical stretch40,47.  Those cells can then be assayed for cell 
damage/survival/proliferation, their media can be assayed for the presence of 
inflammatory cytokines and total protein, and their proinflammatory gene expression 
can be measured using QPCR.  Likewise young and elderly mice can be mechanically 
ventilated; the mechanical properties of their airways as a whole can be measured, their 
airways can be lavaged with saline to collect and measure inflammatory mediators and 
their lungs can be fixed and analyzed with histology/microscopy.  These are all methods 
of analysis that we employed our study to measure and quantify the effect of how aging 
affect the lung and how this intern affects the severity of VILI. 
 
1.3.3 Pulmonary Edema 
In the human body, the existence of interstitial colloidal osmotic pressure and capillary 
filtration pressure causes the filtration of about 20 liters of water out of the blood stream 
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into the surrounding tissues per day.  This creates a need for an opposing gradient in 
order to prevent the accumulation of filtered water in these tissues (edema).  In the 
absence of pathological conditions, these gradients roughly balance one another with 
approximately 17 liters of water being filtrated directly back into the circulatory system 
and the remaining 3 liters being taken up by the lymphatic system and then returned to 
circulation48.   
This balance is of particular importance in the distal lung because pulmonary gas 
exchange occurs at the air liquid interface of the alveoli and thus maintenance of this 
interface critical for normal lung function.  Not surprisingly the accumulation of water in 
the lung alveoli (pulmonary alveolar edema) can lead to dramatic dysfunction of 
pulmonary gas exchange and is potentially fatal 9,48.   
Both increases in vascular pressure, increases in alveolar vascular permeability, 
and increases in alveolar epithelial barrier permeability have been demonstrated to 
drive pulmonary edema.  Additionally each of these forms of dysfunction are known to 
exist in various pathological lung conditions including acute respiratory distress 
syndrome (ARDS) and ventilator induced lung injury (VILI)49.    
 
1.3.4 Alveolar Fluid Clearance 
In the healthy lung, the mechanism for the clearance of alveolar edema is primarily 
linked to that the transportation of sodium and chloride ions out of the alveolus into the 
alveolar capillaries and surrounding interstitial space.  This creates an osmotic pressure 
gradient which drives alveolar fluid clearance into the bloodstream, pleural space, and 
lymphatic system.  Both alveolar epithelial ATI and ATII cells (ATIs, ATIIs) contain 
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sodium/potassium ATPase pumps (Na/K-ATPase).  In addition ATI cells contain the 
epithelial sodium channel (ENaC), the nonselective cation channels (NCC), the cyclic 
nucleotide–gated channels (CNG), and other selective cation channels (SCC).  Chloride 
ions are able to pass through alveolar epithelium through either a trans or paracellular 
route48,50.   
The gradient that is caused by sodium transport causes water to be transported 
by both aquaporin (AQP) 1, and 5, and through paracellular pathways.  However, the 
exact breakdown of how this happens is not immediately clear.  There is experimental 
evidence that in young rats that have AQP-1 and 2 knockout out, both separately and 
together, that there is no significant inhibition of alveolar edema clearance.  However, it 
has also been demonstrated that the experimentally induced up regulation of the 
expression of AQPs that were down regulated by age restores age related losses in 
pulmonary edema clearance function in aged mice50–52. 
 
1.3.5 VILI-Associated Edema 
Edema is a hallmark complication of VILI and acts through several distinct 
pathways.  VILI has been shown to increase lung microvascular pressure and 
transmural pressure and to drive water filtration into the alveolus.  Mechanical 
ventilation (MV) has also been shown to inactivate surfactant within the alveolus.  This 
increases alveolar surface tension which in turn has been shown to increase filtration 
from the microvasculature into the alveolus52,53.   
All of these effects however contribute insufficiently to pulmonary edema to 
account for the pathophysiological state caused by MV.  Instead it is a VILI induced 
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increased in the alveolar epithelial barrier permeability that accounts for the majority the 
observed edema.  It is known that VILI-associated volutrauma can strongly promote 
pulmonary edema.  In one study, during static inflation of sheep lungs the equivalent 
pore radius of the alveolar epithelial barrier (an indicator of barrier permeability) 
increase from 1 to 5 nm.  This fivefold increase was sufficient to allow albumin to diffuse 
freely across the barrier, indicating a major compromise to barrier integrity.  This 
increased permeability persisted or even increased after the cessation of inflation, 
confirming that epithelial barrier damage and not vascular pressure were driving this 
increase in permeability52.    
Additionally, multiple animal models have also shown that when MV with high 
peak pressures causes pulmonary edema, histological analysis inevitably reveals stress 
failure of the alveolar barrier (decompartimentalisation), stress failure of the plasma 
membrane (necrosis), visible denuding of the epithelial basement membrane, and gaps 
in the capillary epithelium50,52,53. 
In addition to primary lung injury sustained through volutrauma, secondary injury 
to the lungs and systemic organs systems through the release of inflammatory 
cytokines (biotrauma) is another major mechanism in the pathogenic process of 
VILI.  Inflammatory cytokines are known to have a profound effect on epithelial barrier 
integrity.  TNF-alpha and IL-1, 6, and 8 are all known to increase the leakiness of tight 
junctions, and are all associated with VILI Induced biotrauma54.  In this way, VILI is able 
to contribute to edema through both direct insult to the alveolar barrier integrity, and 
through the release of inflammatory cytokines which further compromise membrane 
permeability41,53. 
   
33  
 
1.3.6 Age, Edema, and VILI 
Increased age is known to increase the severity of both VILI and edema 
separately.  The changing mechanical properties of the aging lung lead to increases in 
lung compliance which increases the lung susceptibility to over-distention during 
MV27,29,41,55,56.  Additionally, the aging lung also exhibits an increasingly dysregulated 
immune/inflammatory response to injury which has a generally pro-inflammatory 
effect57,58  It has been shown in rats that increased age leads to increased lung 
damage/inflammation and animal mortality in rats that are ventilated with high tidal 
volumes compared to young rats59.  This is in good agreement with the murine data we 
present in chapter two.  It has also been shown that age is a predictive factor in the 
incidence and severity of pulmonary edema.  Aging is known to decrease the 
expression of AQP 1 and 5 in the alveolar membrane of rats which leads to an increase 
in pulmonary edema60.  Additionally, our own data presented in chapter two 
demonstrate that elderly mice treated with injurious MV show both increases in 
pulmonary edema and decreases in 4 hour survival compared to similarly ventilated 
younger mice. 
   
1.3.7 Fluid Support and Hemodynamics During MV 
MV has a strong effect on a patient's hemodynamics.  Overall, MV has a tendency to 
decrease blood pressure and cardiac output.  In addition to strong insult to the 
cardiovascular system, prolonged dysfunction of the circulation is also extremely 
stressful on a patient’s renal system.  These MV related complications can prove to be 
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fatal to patients with already in compromised pathophysiological states49,61. For this 
reason there is a general concern among clinicians regarding an attempt to normalize 
the hemodynamics of ventilator patients.  Although the exact effects are still being 
debated, fluid support has been shown to increase the blood pressure and improve the 
overall hemodynamics in ventilated rats61.  However, the same study showed that these 
rats, while having improved hemodynamics, displayed increases in edema and 
anemia.  Additionally, in human ventilation patients it has been shown that conservative 
fluid management strategies decrease pulmonary edema. 
These results may at first be somewhat surprising since it has been established 
ventilation induced pulmonary edema is caused primarily by decreases alveolar 
membrane permeability and not modified hemodynamics in the alveolus.  Thus the 
impact of this and other studies that correlate high volume fluid-management with 
pulmonary edema is that once alveolar barrier permeability is compromised, only minor 
increases in intravascular pressure and drops in ontotic pressure are required to 
generate large edema. The molecular aspects that influence pulmonary edema, both 
upstream and downstream, are currently understudied. One key player in the 
mechanism may be stress in the endoplasmic reticulum.  
 
1.4.0 ER Stress Background 
Protein molecules are vital players in virtually every cellular process.  However, their 
useful bioactivity is not an innate property imbued through their synthesis by the 
ribosomes alone.  Instead each nascent polypeptide chain must go through a 
conformational change into its characteristic or ‘native’ 3 dimensional form in order to 
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have its full physiological functionality62,63.  Every part of the protein formation process 
that occurs after translation of the polypeptide chain by is known as protein folding.  For 
proteins that are eventually to be secreted out of the cell or sorted to other organelles 
this folding takes place takes place in the cisternae of the Endoplasmic Reticulum 
(ER)37.   
 The ER itself is a membrane enclosed organelle performing numerous cellular 
functions including lipid biosynthesis and calcium storage and sequestration.  However, 
arguably the most important function of the ER is its role as the site of protein folding as 
the majority of its resident proteins are dedicated to this process64.  An N-terminal signal 
sequence on these proteins interacts with a signal recognition particle (SRP) which lead 
the RNA, Ribosome, polypeptide complex to the ER.  Once docked, the sequence is 
translated directly into the luminal environment of the ER.  The folding process itself 
may start as soon as the nascent polypeptide chain begins to enter the ER while the 
rest of the chain is still undergoing translation.  Thus the N-terminus of the polypeptide 
chain may undergo folding while the while the C-terminal is still being synthesized64,65.   
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The native states of almost all proteins correspond to the three dimensional 
conformation of their nascent polypeptide coil that are the most thermodynamically 
stable under physiological conditions 66. Therefore although one might imagine a linear 
set of consecutive folding steps that leads each protein from nascent to native, the 
protein instead meanders down an energy landscape (figure 16).   
 
 
 
Figure 16: A schematic energy landscape for protein folding.  Reprinted from Reynaud et al67.  
 
And although the potential paths are many, at each step the protein chooses a 
new conformation that further reduces its free energy until, if all goes well, it arrives at 
its native conformation.  This means that ultimately is it the amino acid sequence itself 
that determines native conformation of each resultant protein66.  
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 However, because it is a stepwise process, it is a certainly the case that at 
intermediate stages of this process some regions that would normally be hidden inside 
the protein during its native conformation are exposed to the crowded milieu of the 
ER68.   This leaves intermediately folded proteins vulnerable and prone to inappropriate 
interactions with other molecules.  In the case of exposed hydrophobic residues 
intermediate or misfolded proteins will have a strong tendency to aggregate together.  In 
all as many as 30% of synthesized proteins never attain their fully native conformation69.  
 All hope is not lost however.  The cell has evolved a quality control system to 
bolster the success of this folding process.  The folding process inside the ER is 
assisted at every stage by molecular chaperones and ER folding enzymes65.  Molecular 
chaperones are proteins that aid other proteins to attain their native conformation but 
are not part of the final protein structure.  In the ER protein folding process the primary 
function of the molecular chaperones is to shield the hydrophobic binding sites of the 
intermediate or misfolded proteins.  Different chaperones specialize in assisting at 
various different stages of the folding process.  Some chaperones assist the nascent 
protein as they are being translocated into the ER while others aide the final 
conformation into native proteins.  But in all cases along this continuum these 
chaperones effectively sequester the proteins and provide them with a privileged folding 
environment to prevent premature folding or aggregation.  There are still other 
chaperones that have the ability to ‘rescue’ misfolded or aggregated proteins and allow 
them to attempt to refold properly 66,70(figure 17).   
 But for proteins who are hopelessly misfolded or aggregated there are multiple 
chaperones and folding sensors that have the ability to identify them.  These proteins 
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are then transported outside of the cell and degraded.  Because there are very few 
protein folding chaperones anywhere else in the body it is crucial that highly efficient 
quality control system be in place to prevent misfolded proteins from being packaged 
transported out of the ER71.  
 
Figure 17: Regulation of protein folding in the ER.  Reprinted from Reynaud et al67 
 
As the folding of the ER proteins is guided by the chemical forces acting on the 
polypeptide sequences, the maintenance of homeostasis of the ER environment is 
critical for this process.  There are many pathophysiological conditions however that can 
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perturb this delicate balance including disruptions in calcium homeostasis, 
glucose/energy deprivation, redox changes, ischemia, hyperhomocystinemia, and viral 
infections and mutations.  This impairment in folding can cause an increasing 
accumulation of unfolded and/or aggregated proteins known as ER Stress72.   
 The evolved response to ER Stress is known as the unfolded protein response 
(UPR) and consists primarily of three branches.  The signaling of each branch is 
transduced across the ER membrane through a one of three transmembrane proteins:  
PKR like ER kinase (PERK), inositol requiring element-1 (IRE-1), and activating 
transcription factor 6 (ATF6).  Each of these three proteins are held inactive  by being 
bound to BiP, a peptide-dependent ATPase and member of the heat shock 70 protein 
family.  However, when the unfolded/aggregated proteins begin to accumulate BiP 
dissociates from the three signaling molecules and they become active (figure 18)73.   
 IRE1 dimerizes then auto-transphosphoyilizes.  It then produces the mRNA 
which encodes unspliced x box-binding protein 1 (XBP1u) to produce active 
transcription factor spliced (XBP1s)74.  XBP1s which includes the transcription factors 
for several molecular chaperones including BiP and GRP94.  XBP1s also encodes for 
the transcription of genes associated with ER-associated degradation (ERAD).  The net 
effect is an increase in the available protein folding chaperones and an upregulation of 
the degradation of misfolded proteins.   
PERK phosphorylates initiation factor eukaryotic translation initiator factor 2α 
(eIF2α) which inhibits general translation into the cell with the exception of BiP and 
ATF4 which are instead translated more efficiently75.   PERK also inhibits several 
transcription factors.  This general decrease in the rate at which proteins are being 
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transcribed into the ER gives the protein folding apparatus extra time to try to clear the 
accumulation of misfolded proteins.  PERK also upregulates Nrf2 which upregulates 
antioxidant response76.  This is of particular importance in understanding the therapeutic 
potential of VitC to attenuate ER stress. VitC is a powerful anti-inflammatory and anti-
oxidant77 both of which have the potential to strongly interact with the ER stress 
pathway.
 
 Figure 18: Diagram of ER Stress Pathway. Reprinted from Reynaud et al72 
  
 ATF6 is localized in the ER membrane when the ER is unstressed.  When 
cleaved from BiP AFT6 is transported to the golgi apparatus where it is cleaved.  The 
cytosolic dominant fragment (ATF6f) upregulates expression of the gene encoding for 
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ERAD and XBP178.  As discussed above the upregulation of these genes stimulates 
degradation of misfolded proteins.  
 If the ER stress continues unabated however it leads to pro-apoptotic signaling 
and cell death.  The ER stress induced is mediated primarily through C/EBP 
homologous protein (CHOP) also known as growth arrest and DNA damage 153 
(GADD 153) which downregulates the anti-apoptotic protein BCL-2, induces the 
expression of some BH3-only proteins and upregulates growth arrest and DNA 
damage-inducible 34 (GADD34)65.  CHOP is downstream of both the PERK and ATF6 
pathways.  The PERK induced eIF2 in the presence of sustained ER stress will 
upregulate nuclear factor-kappaB (NFκB) and ATF4.  And under prolonged ER stress 
ATF4 in turn upregulates CHOP.  IRE1a may upregulate p53 which along with ATF4 
and CHOP may upregulate BH3-only proteins79.  
 
Figure 19: Time dependent ER stress pathway.  Reprinted from Hetz et al79.  
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 As we can see from the  above diagram there is a balance between adaptive 
responses to ER stress and the apoptosis phase whose nature is such that failure to 
sufficiently resolve the UPR will upregulate apoptosis (figure 19)79.   Predictably there 
are many disease states in which ER stress plays a key role.    
 We know that as people age there is a general shift away from the adaptive 
phase of the UPR towards the apoptotic signaling pathway72.  In addition to promoting 
inflammation, this age-associated decrease in the efficiency of the UPR also leads to 
the accumulation of insoluble proteins or plagues in a variety of organs including the 
liver, spleen, or brain.  This in turn contributes to a host of age-associated pathologies 
including age-related neurodegenerative disorders.  For example protein aggregation is 
a hallmark of Alzheimer's disease, Parkinson’s, and prion disease80.  It was 
experimentally determined that under basal conditions that the expression of 
chaperones calnexin, protein disulfide isomerase (PDI), and Grp78 are downregulated 
in the aged hypothalamus81.  Each of these chaperones is a constituent in the normal 
protein folding process.  Conversely, ubiquitination which plays a key role in the 
apoptotic arm of the UPR pathway is increased in the aged hippocampus.  The 
downstream effects of this pattern were experimentally confirmed as well.  When ER 
stress was induced in young VS old rats via intra-hippocampal lactacystin injection the 
old rats expressed less folding chaperones and Caspase-12 and young did not81. 
 Key protein folding chaperones BiP, PDI, calnexin and GRP94 also become 
increasingly impaired with age82,83.  Over time these chaperones become increasingly 
oxidized which may impair their functionality.  For several of these chaperones 
reductions in oxidation correlate significantly with diminished enzymatic activity.   
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The universality of both aging and ER stress makes any interaction between them as 
ubiquitous as even the most common of pathologies.  It is thus not surprising that as we 
continue to further investigate this interaction that we are compiling an ever growing list 
of diseases of aging in which ER stress is a key factor.  Our ultimate goal is to discern 
the role of aging and ER stress in VILI.  
   
1.5 Specific Aims 
Despite its necessity as a potentially life-saving clinical intervention, MV can result in 
ventilator induced lung injury (VILI).  The proposed mechanisms of VILI (volutrauma/, 
atelectrauma, biotrauma) were discussed in chapter one of this dissertation.  Also as we 
discussed previously age is a predictive factor in the severity of VILI and the largest 
population of patients requiring MV is the elderly.  However, the exact relationship 
thought which age-associated changes in pulmonary physiology interact with VILI is not 
well understood which has made it difficult for physicians to create age-dependent 
ventilator protocols or preventative treatments for VILI. 
We hypothesized that there is an overall age-associated increase in the severity 
of the ventilator induced lung injuries that act to promote pulmonary edema.  We 
hypothesized that this upregulation of edema promoting stimulus synergizes with a 
general and independent age-associated increase in the susceptibility to and severity of 
pulmonary edema.  Furthermore we hypothesized that this age-associated increase in 
the severity of VILI induced pulmonary edema itself promotes further injury and 
inflammation which in turn positively feeds back to further promote edema and injury.   
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We believed this VILI induced positive feedback loop through the pulmonary 
edema pathway is ultimately an important cause of the age-associated increase in 
ventilator-associated mortality.  And finally we hypothesize that since the primary 
mechanical driving force which filters fluid into the lungs is trans pulmonary pressure, if 
we administered a low fluid protocol to our murine subjects it would attenuate their age-
associated increase in VILI-assocaited edema, inflammation, injury and mortality.  
We tested this hypothesis in vivo by mechanically ventilating young (8 weeks) 
and old (20 months) mice with either a high tidal volume (HVT) or low tidal volume 
(LVT) ventilation protocols and with either a conservative or liberal fluid treatment 
protocol.   During ventilation we measured subjects’ pulmonary mechanics and mortality 
rates.  Concluding ventilation we measured pulmonary edema, histological lung injury, 
and relative cytokine population in the alveolar lavage fluid.   
 
Specific Aim 1: Measure the effect of novel low fluid treatment protocol on the age-
associated increase in the severity of VILI and ventilator induced 
mortality. 
 
We also hypothesized that the known age-associated increase in the susceptibility and 
severity of ER stress is a causal mechanism in the age-associated increase in the 
severity of ventilator-associated biotrauma.  We hypothesized that old ATII cells 
themselves exhibit greater inflammation and injury downstream of an age-associated 
increase in mechanical stretch induced ER stress.  Additionally, since we hypothesized 
ER stress as being upstream of this age-associated increase in stretch induced 
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inflammation and injury, we further hypothesized that treatment with an ER stress 
inhibitor would attenuate both the ER Stress and inflammation/injury as well. We tested 
this hypothesis in vitro by harvesting and culturing the alveolar epithelial ATII cells of 
young and old mice, exposing them to cyclic mechanical stretch, and measuring their 
inflammation and injury.  Cells were treated with either an ER stress inhibitor or sham 
control.   
 
Specific Aim 2: Determine if ER stress is an upstream regulator of age-associated 
mechanical stretch induced inflammation and injury in primary 
alveolar epithelial ATII cells.  
 
In mice, VitC deficiency has been shown to increase the severity of acute lung injury 
(ALI) and pulmonary edema.  Treatment with injections of VitC has been proven to 
attenuate these effects both in VitC deficient and sufficient mice[8].  Knowing the 
mechanistic role that pulmonary edema plays in the age-associated increase in the 
severity VILI, we hypothesized that VitC treatments would resolve edema and confer a 
protective effect on old murine ventilation subjects. 
 
Specific Aim 3: Evaluate the efficacy of VitC as a treatment for Edema and VILI in 
old mice. 
 
When taken together, these data greatly enhance our working understanding of the 
mechanistic relationships that drive the age-associated increase in the severity of VILI.  
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Even more importantly the resolution of each of these aims provides a much needed 
therapeutic target for preventative VILI treatments.  
 
2.0 
Conservative Fluid Management Prevents Age-Associated Ventilator Induced 
Mortality 
A research paper on by our group on which I was the primary author titled 
“Conservative Fluid Management Prevents Age-Associated Ventilator Induced Mortality” 
was successfully submitted and published to the Journal of Experimental Gerontology.  
This chapter is contains the body of that work as published.   
 
2.1.0 Introduction 
Advanced age is known to beventilator-associated with increased severity of ventilator-
induced lung injury (VILI) 29.  Setzer et al recently demonstrated that HVT (24 ml/kg) MV 
caused more lung injury in old rat subjects than in their younger counterparts.  Lung wet 
to dry rations, lavage protein and cytokine concentrations, and systemic markers of 
inflammation were all elevated in the older HVT MV subjects59.  Additionally, it has been 
shown that short-term mechanical ventilation with low tidal volume and hyperoxia 
increases pulmonary edema, lung inflammation, and decreases diaphragm function in 
old rats subjects compared to young adults 84.  However, the exact mechanism(s) 
through which this relationship between aging and VILI is mediated remain ill defined.  
Consequently, preventative strategies for the age-associated increase in ventilator 
mortality are currently unknown.  The changing mechanical properties of the aging lung 
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lead to increases in lung compliance which can predispose the lung to over-distention 
and increased susceptibility to atelectasis during mechanical ventilation 41,55,56,85.  
Further, the aging lung exhibits increasingly dysregulated immune/inflammatory 
responses to injury leading to pathological increases in pro-inflammatory behavior 57,59. 
Pulmonary edema is a hallmark of VILI53.  The incidence and in-hospital mortality 
rates of patients presenting with pulmonary edema is also known to increase with 
patient age86,87.  Both the presence of pulmonary edema in ventilated patients and their 
overall survival rates can be affected by fluid management strategies61.  Recent studies 
show that conservative fluid management can decrease pulmonary edema, increase 
ventilator free days, and increase overall survival of patients with acute respiratory 
distress syndrome (ARDS) 59,88.  However, patients undergoing mechanical ventilation 
with inadequate fluid support are also at risk of developing hypovolemia which overtime 
can lead to multiple organ system failure 28.  Therefore administering optimal fluid 
balance is crucial for mechanical ventilator patient survival and recovery.  Despite 
known benefits of conservative fluid protocols for patients with ARDS, its effects on VILI, 
interaction with patient age, and the role that they both may play in ventilator-associated 
mortality rates has yet to be established.   
We hypothesized that high tidal volume (HVT) mechanical ventilation would 
induce lung injury, degrade pulmonary mechanics, and increase pulmonary edema in 
older murine subjects.  Further, we hypothesized that a greater sensitivity to these 
pathologies would result in an age-associated increase in ventilator-associated 
mortality.  Finally, we hypothesized that age-associated increases in injury and mortality 
could be attenuated with a conservative fluid support strategy.  To establish the role 
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pulmonary edema plays in age-associated increases in VILI and ventilator-associated 
mortality and to evaluate fluid support protocols as a potential preventative treatment, 
we investigated the outcomes of both liberal and conservative fluid support strategies 
during high and low tidal volume mechanical ventilation in both young and old mice.   
 
2.2.0 Materials and Methods 
2.2.1 Animal Use:  This study was approved by the VCU Institutional Animal Care and 
Use Committee (protocol number AD10000465).  Male C57BL6 mice were used in 
these experiments.  All animal experiments were carried out under IACUC University 
guidelines.  
2.2.2 Age Groups:  Age group I (Young): Young adult animals, 2-3 months of age, 
weighing 25 ± 3 g. Age group II (Old): Old animals, 20-22 months of age, weighing 35 ± 
11 g.  Ages of our young and old murine groups respectively were based on correlations 
between murine lifespan and known age-associated morphological changes in murine 
lung (17)(29).  
2.2.3 Mechanical Ventilation:  Young and old animal subjects were anesthetized with 
an intraperitoneal (IP) injection of 80mg/kg pentobarbital.  In addition to anesthesia our 
MV regimen required that we arrest the subjects’ spontaneous breathing with 
administration of a paralytic.  This was accomplished with IP injection of 0.8 mg/kg 
pancuronium bromide at the 0hr and 2hr time points.  Depth of subject anesthesia was 
monitored continuously via EKG transducer monitors included in FlexiVent small animal 
ventilator (Scireq) hardware.  To maintain an appropriate level of anesthesia over the 
course of ventilation pentobarbital redoses of 40mg/kg were administered as needed 
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when subject heart rate exceeded 350 bpm.  Each subject was randomized into the 
following treatment groups according to age: Young Low Tidal Volume (LVT), Young 
High Tidal Volume (HVT), Old LVT, and Old HVT.  Following group assignment, 
subjects were mechanically ventilated with either LVT (8mL/kg, 125 BPM, 3cm H20 
positive end expiratory pressure, [PEEP]) or HVT (25mL/kg for Young, 18mL/kg for Old, 
90 BPM, 0cm H20 PEEP) ventilation protocol for either 1hr or 4hrs using a FlexiVent 
small animal ventilator (Scireq).  LVT and HVT ventilation patterns and four-hour 
ventilation protocol were based on previously published in vivo models 89.  Difference in 
tidal volumes of young and old HVT groups reflects a normalization of tidal volume 
across age based upon ideal body weight.  Mice are considered to be adult at 2-3 
months, but our measurements indicated that our 20-22 month old animal subjects were 
on average ~30% more massive than their younger counterparts.  To better replicate 
clinical protocols the tidal volumes for our HVT ventilation were established using 
ideal/predicted body weights.  The tidal volume for the old HVT group was therefore 
multiplied by 0.7, or the ratio of the average weight of the young subjects to that of the 
old.  This gave an adjusted average tidal volume of 625ul±50ul and 630ul±62ul for the 
young and old HVT groups respectively.  
2.2.4 Fluid Support Protocol:  Animal subjects were administered either liberal (high) 
or conservative (low) fluid management protocols.  Animals managed under high fluid 
received anesthesia with pentobarbital at a concentration of 10 mg/ml in saline and 
received IP infusions of saline at 100µL/hr.  For a 25 gram subject requiring an hourly 
redose of pentobarbital the total 4hr saline infusion volume would be ~1ml.  Animals 
managed under low fluid protocol were anesthetized with pentobarbital at 20 mg/ml and 
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received no IP saline infusions.  For a 25 gram subject requiring an hourly redose of 
pentobarbital the total 4hr saline infusion volume would be ~0.35ml. 
2.2.5 Lung Mechanics:  At the 0, 1, 2, 3, and 4hr time points the following forced 
inspiratory maneuvers: 1) Deep Inflation v7.0, 2) Snapshot-150 v7.0, and 3) PVs-V v7.0 
were performed using the included FlexiWare software package (Scireq).  Deep inflation 
acts as a recruitment maneuver and measures total lung capacity (TLC).  Snapshot 
measures lung tissue compliance.  The pressure volume (PV) maneuver inflates the 
lung to a sequence of linearly increasing then decreasing volumes while measuring the 
corresponding airway pressures.  With these data the PV maneuver generates 
respiratory pressure-volume loops from which the PV-loop area (hysteresis) is 
calculated.  For subjects who died during ventilation the last set of mechanical data 
points taken prior to death were included in analysis where possible.  
2.2.6 Euthanasia:  At the end of the 1hr and 4hr ventilations respectively each animal 
subject was fully exsanguinated and removed from mechanical ventilation.   
2.2.7 Bronchoalveolar Lavage Fluid Collection:  Bronchoalveolar lavage was 
performed by instillation of saline using gravity feed driven flow at a height 30cm.  This 
method was preferred over a forced installation to preserve lung architecture for 
histological analysis of alveolar airspace enlargement.  Saline flowed freely into the lung 
until it stopped naturally.  The installation tube and mouse were then inverted to allow 
the saline to flow freely back out and into a collection tube.  This process was repeated 
three times. An average of 2.5 - 3.5mls of total bronchoalveolar lavage fluid (BALF) per 
subject was obtained using this technique.  
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2.2.8 Bronchoalveolar Lavage Fluid Cytology:  BAL fluid was centrifuged at 300 x G, 
4°C for 8 minutes.  Supernatants were removed and cell pellets re-suspended in saline.  
Cells were then mounted onto glass slides using a cytospin device (Shandon).  Cells 
were stained (3 Diff-Quik solutions staining kit) and cover-slipped.  Cell populations 
were then analyzed using microscopy (Olympus) and the ratios of lymphocytes, 
leukocytes, and macrophages were determined.  
2.2.9 Bronchoalveolar Lavage Fluid Protein Concentration:  BCA assay analysis 
(Pierce) of protein concentration was performed on all BAL fluid supernatants according 
to manufacturer’s instructions. 
2.2.10 Lung Histology:  Left lungs were held at constant pressure, fixed with 10% 
formalin, sectioned, and stained with H&E.  Airspace enlargement, which quantifies 
relative differences in alveolar airspace area within lung histology sections, was 
measured and analyzed using in-house custom code written in MATLAB.  This code 
quantified enlargement using a previously defined mean weighted enlargement metric 
(18). The weight of each airspace in the metric was dependent on the variance and 
skewness of its size. Stained slides were dehydrated and mounted using Permount 
mounting medium (Fisher) and imaged using an Olympus IX71 Microscope (Olympus). 
2.2.11 Lung Wet to Dry Weight Ratios:  From each animal subject, right lungs were 
excised, weighed, fully desiccated then lyophilized for 48 hours.  Specimens were then 
weighed and a wet weight to dry weight ratio calculated 90.  To prevent introduction of 
erroneous fluid to this measurement wet to dry ratios were not performed on subjects 
for whom BALF had been collected. 
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2.2.12 Non-Ventilated Controls:  Measurements of each experimental variable except 
for pulmonary biomechanics was performed on non-ventilated control animals.  
2.2.13 Statistical Analysis: All quantitative experimental studies were performed with a 
minimum of n=3 however the values vary between individual groups experiments.  A 
more in-depth explanation of the variation in N values is given in the supplement.  
Survival statistics were performed with Kaplan-Meyer estimation.  For wet to dry data 
analysis two way ANOVA was used to establish pairwise differences across age and 
one way ANOVA with Tukey tests were used to establish within group differences.  All 
other statistics were performed using two way ANOVA. P values of <0.05 were 
considered significant. We used GraphPad Prism 5 statistical analysis software. 
 
2.3.0 Results 
2.3.1 Four Hour High Fluid Survival Rate:  4hr survival curve for old subjects 
ventilated with HVT and high fluid support was statistically significantly lower than that 
observed in all other groups (figure 20).  In all, only four of twelve old HVT subjects 
survived the 4Hr duration of their respective ventilations.  By contrast, only one old HVT 
subject on the low fluid support protocol died during mechanical ventilation.  
Additionally, only one old LVT subject and one young LVT subject died during 
mechanical ventilation.  No young HVT subjects died during mechanical ventilation 
(figure 20).   
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Figure 20: 4Hr Survival Rate.  Survival rate in the Old HVT-HF group was significantly less than all other groups.  Data is presented as survival percentage N = 10 for Young LVT-HF, 10 for Young HVT-HF, 3 for Young HVT-LF, 7 for Old LVT-HF, 12 for Old HVT-HF, 8 for Old HVT-LF ***p<0.001. 
 
2.3.2 One Hour Lung Wet to Dry Ratios:  Wet to dry ratios for each of the 1hr 
ventilation groups were measured (figure 21A).  A statistically significant group-wise 
difference across age was observed with the older murine groups exhibiting significantly 
greater wet to dry ratios than the young.  The wet to dry ratios for young HVT subjects 
receiving high fluid protocol was significantly greater than that observed in the young 
non-ventilated group (figure 21A).  The wet to dry ratio of old HVT subjects receiving 
low fluid protocol was significantly lower than that observed in the old HVT subjects who 
received high fluid protocol and the old non-ventilated group (figure 21A).   
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Figure 21: A. 1Hr Lung Wet to Dry Ratios.  There was a group wise statistically significant difference across age with old groups having significantly greater lung wet to dry ratio than young.  The Young HVT-HF group was significantly greater than in the Young Non-Ventilated group.  The Old HVT-LF group was significantly less than in all other old groups respectively.  Data are presented as mean +/- st.dev N = 4 for Young Non-Vent,  4 for Young HVT-HF, 4 for Young HVT-LF, 4 for Old Non-Vent,  4 for Old HVT-HF, 5 for Old HVT-LF.  B. 4Hr Lavage Protein Concentration.  The Old HVT-HF group concentration was significantly greater than that of all other old groups respectively.  N = 4 for Young Non-Vent, 4 for Young LVT-HF, 7 for Young HVT-HF, 3 for Young HVT-LF, 4 for Old Non-Vent, 4 for Old LVT-HF, 4 for Old HVT-HF, 5 for Old HVT-LF *p<0.05.   
 
2.3.3 Four Hour Bronchoalveolar Lavage Fluid Protein Concentration:  BAL fluid 
protein concentrations were measured for each animal subject surviving 4hr ventilation 
(figure 21B).   There was not a statistically significant group wise difference in lavage 
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protein concentration across age.  Within the old group, the lavage protein 
concentration of subjects ventilated with HVT and high fluid support was significantly 
greater than that of all other old groups respectively.  Similar trends were seen between 
the young groups but none reached statistical significance.   
 
 
 
2.3.4 Bronchoalveolar Lavage Fluid Cytology:  Cytological differentials were 
measured on the BAL fluid of each subject surviving 4Hr ventilation (Table 1).  The 
monocyte differentials of Old HVT high fluid group were significantly greater than those 
of both the Young Non-Ventilated and Old Non-Ventilated groups. No other statistically 
significant differences were observed. 
Table 1: Cellularity in BALF. Data presented as absolute cell numbers in broncoalveolar lavage and as cell differentials (percentage of counted cells). Monocyte differential < Young Non-Ventilated and Old Non-Ventilated.  Data are presented as mean +/- st.dev N=4 for Young Non-Vent, 3 for Young LVT – HF, 6 for Young HVT – HF, 3 for Young HVT – LF, 6 for Old Non-Vent, 4 for Old LVT – HF, 4 for Old HVT – HF, 5 for Old HVT – LF *p<0.05. 
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2.3.5 PV Loop Hysteresis:  PV loops were generated hourly using the Flexivent 
software (Scireq) for each surviving animal subject. Representative PV loops are shown 
in figure 22. The hysteresis values of each group were normalized with their respective 
0hr values (figure 23).  There was a group wise difference across age with old groups 
having significantly greater 1Hr PV loop hysteresis than young.  1Hr PV loop hysteresis 
of Old HVT high fluid group was significantly greater than that of the Old HVT low fluid 
group (figure 23A).  The 4Hr PV loop hysteresis of the old HVT high fluid was 
significantly greater than that of both the old LVT high fluid and old HVT low fluid groups 
(figure 23B). Similar trends were seen between the young groups but none reached 
statistical significance. 
Figure 22: A. Representative 4Hr PV Loop for a Young LVT-HF subject.  B. Representative 4Hr PV Loop for an Old LVT-HF subject. C. Representative 4Hr PV Loop for a Young HVT-HF subject.  D. Representative 4Hr PV Loop for an Old HVT-HF subject. 
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Figure 23: A.  1Hr PV Loop Hysteresis. Hysteresis in the Old HVT-HF group was significantly greater than Young HVT-HF and Old HVT-LF groups. Data are presented as mean +/- st.dev N=7 for Young HVT-HF, 7 for Young HVT-LF, 9 for Old HVT-HF, 12 for Old HVT-LF.  B. 4Hr PV Loop Hysteresis.  Hysteresis of the Old HVT-HF group was greater than that of the Old LVT-HF and Old HVT-LF groups.  N=5 for Young LVT-HF, 6 for Young HVT-HF, 3 for Young HVT-LF, 5 for Old LVT-HF, 4 for Old HVT-HF, 5 for Old HVT-LF *p<0.05 **p<0.01. 
A 
B 
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Figure 24: A. 1Hr Lung Compliance.  There was a significant group wise across age with the old groups having a greater compliance than the young.  1Hr lung compliance in the Old HVT-HF group was significantly greater that of the Old HVT-LF group.  Data are presented as mean +/- st.dev N=11 for Young HVT – HF, 4 for Young HVT – LF, 14 for Old HVT – HF, 7 for Old HVT – LF.  B. 1Hr Total Lung Capacity.  There was a significant group wise difference across age with the old groups having a greater TLC than young.  1Hr TLC in the Old HVT-HF group was significantly greater that of the Old HVT-LF group.  N=4 for Young HVT – HF, 4 for Young HVT – LF, 14 for Old HVT – HF, 14 for Old HVT – LF.  C. 4Hr Lung Compliance.  There was a significant group wise difference across age with the old groups having greater lung compliance than the young.  4Hr lung compliance in the Old HVT-HF group was significantly greater that of the Old 0Hr and Old HVT-LF groups.  N=11 for 0Hr Young, 7 for Young LVT – HF, 8 for Young HVT – HF, 3 for Young HVT – LF, 16 for 0Hr Old, 6 for Old LVT – HF, 4 for Old HVT – HF, 6 for Old HVT – LF.  D. 4Hr Total Lung Capacity.  There was a significant group wise difference across age with the old groups having a greater TLC than young.  4Hr TLC in the Old HVT-HF group was significantly greater that of the Old HVT-LF group.  N=11 for 0Hr Young, 7 for Young LVT – HF, 9 for Young HVT – HF, 3 for Young HVT – LF, 16 for 0Hr Old, 6 for Old LVT – HF, 4 for Old HVT – HF, 6 for Old HVT – LF, *p<0.05 **p<0.01 ***p<0.001 ****p<0.0001. 
A B 
C D 
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2.3.6 Lung Compliance:  Lung compliance was measured hourly using the Flexivent 
software (Scireq) for each surviving animal subject (figure 24).  There was a significant 
group wise difference across age of both the 1Hr and 4Hr lung compliance with old 
groups having greater compliance than young. (figure 24 A, C).  The 1Hr lung 
compliance of the old HVT high fluid group was significantly greater than that of the 
HVT low fluid group (figure 24A).  The 4Hr lung compliance of the old HVT high fluid 
group was greater than that of the old HVT low fluid group (figure 24C).  There was a 
strong non-significant trend with the old 4Hr HVT high fluid groups having a greater 
mean than the old 4Hr LVT low fluid group.    
2.3.7 Total Lung Capacity: Total Lung Capacity (TLC) was measured hourly using the 
Flexivent software (Scireq) for each surviving animal subject (figure 24).  There was a 
statistically significant group wise difference across age of both the 1Hr and 4Hr TLC 
with the old groups having greater TLC than young (figure 24 B, D).  The 1Hr TLC of the 
old HVT high fluid group was significantly greater than that of the HVT low fluid group 
(figure 24B).  The 4Hr TLC of the old HVT high fluid group was significantly greater than 
that of the old HVT low fluid group (figure 24D).  There was a strong non-significant 
trend with the old 4Hr HVT high fluid group having a greater mean than the old 4Hr LVT 
high fluid group.  
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2.3.8 Airspace Enlargement:  Representative histological images of lung stained with 
H&E of both young and old animal subjects ventilated with HV or LV are presented in 
figure 25A-D.  Airspace enlargement and an increased infiltration of erythrocytes could 
clearly be seen in images corresponding to both increased age and HVT ventilation.  
Low fluid protocols visually attenuated these effects.   Airspace enlargement was 
quantified and calculated for each subject reaching 4hrs of mechanical ventilation.  
There was a significant group wise difference in airspace enlargement across age with 
old groups having a greater value that young.  Airspace enlargement of old subjects 
ventilated with HVT and high fluid was significantly greater than that of all other groups 
(figure 26). 
A B C 
D E F 
Figure 25: A, B, C, D, E, F. Representative 4Hr histological H&E images of A. Young LVT-HF, B. Young HVT-HF, C. Young HVT-LF, D. Old LVT-HF, E. Old HVT-HF, and F. Old HVT-LF lung sections respectively. 
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2.4 Discussion  
The first aim of this study was to establish that older mouse subjects when subjected to 
HVT MV exhibit an increased severity of ventilator-induced lung injury as was recently 
reported in an aging rat model 59.  Wilson et al established that significant stretch 
induced lung injury in young healthy mice requires mechanical ventilation with tidal 
volumes approaching 40mg/ml 91.  Consequently most models of VILI use similarly high 
(>30mg/ml) VT and/or inspiratory pressures to induce injury.  These settings however 
are generally considered significantly higher than those used in the clinical management 
of patients 91,92.  Setzer et al demonstrated that the increased sensitivity of the aging rat 
lung to mechanical ventilation allowed their group to achieve significant VILI with tidal 
volumes of 16-24mg/kg 59.  So while a tidal volume of 40mg/kg may be more 
conventionally referred to as “High Tidal Volume”, our HVT protocol is both sufficient to 
Figure 26: Airspace Enlargement.  There was a statistically significant groupwise difference across age with old groups having significantly greater enlargement than young.  Enlargement was greater in the Old HVT-HF group than in all others.  Data are presented as mean +/- st.dev  N = 3 for Young Non-Vent, 6 for Young LVT-HF, 6 for Young HVT-HF, 3 for Young HVT-LF, 3 for Old Non-Vent, 3 for Old LVT-HF, 4 for Old HVT-HF, 3 for Old HVT-LF **p<0.01. 
   
62  
cause ventilator induced injury and mortality in our older subjects and is closer to clinical 
relevance than other higher HVT standards.  
Each of our experimental measures demonstrates a significant pattern of age-
associated increase in inflammation and injury.  Our second aim was to determine 
whether administration of a conservative fluid management strategy alone would 
attenuate these effects.  While fluid management has long been an important issue in 
clinical medicine; the role of fluid management on the development and outcome of VILI 
had yet to be quantitatively studied in-vivo.  The addition of conservative fluid support to 
our HVT ventilation protocol attenuated VILI and significantly decreased the mortality 
rate in older subjects. 
Patient mortality is the gravest complication of mechanical ventilation.  In our 
study neither advanced age nor HVT ventilation alone significantly increased subject 
mortality.  Only with the combination of advanced age and HVT did our study yield a 
profound decrease in our subjects’ survival (figure 18).  Considering the epidemiology of 
VILI the experimental validation of the age-associated increase in ventilator mortality is 
already of paramount importance.  Potentially even more meaningful however was that 
we were able to completely attenuate the age-associated increase in our subject’s HVT 
mortality with the administration of a low fluid protocol.  Pulmonary edema, pulmonary 
mechanics, lung histology, and BALF cytology data all give a strong testimony that the 
resolution of VILI induced edema itself is a primary mechanism through which this low 
fluid protocol is able to enact such a dramatically protective effect.   
Pulmonary edema is a hallmark of VILI and the severity and susceptibility to 
pulmonary edema increases with age 50,93–95.  Some of the driving forces behind 
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development and progression of pulmonary edema both in general and in VILI are 
increases in pulmonary intravascular pressure, decreased epithelial barrier 
integrity/increased permeability, and increased local and systemic inflammatory 
cytokine presence.  Since conservative fluid strategies decease intravascular pressure, 
it is not surprising that a body of data has emerged linking them to decreased 
pulmonary edema and increased survival rates both in animal and human studies of 
ARDS 88,95,96.  However, liberal fluid management strategies are not wholly without 
merit.  Liberal fluid resuscitation is known to have positive effects on blood pressure and 
other hemodynamic factors in human studies 95. 
The role of aquaporin channels in pulmonary fluid clearance and how they my 
specifically interact with VILI, aging, and edema is complicated at the very least.  
Zhongguo et al showed that aquaporin channel 1 and 5 (AQP1& AQP5) expression 
decreases in rats with hyperoxia induced lung injury and correlates with increases in 
pulmonary edema.  And although low tidal volume mechanical ventilation was not found 
to increase alveolar barrier permeability or pulmonary edema in rats, it was shown to 
increase AQP1 and AQP5 expression.  Age is known to be a predictive factor in the 
incidence and severity of pulmonary edema 29,97.  Zhang et al showed that aging lungs 
exhibit decreased aquaporin channel expression 60.  Additionally, it is known that age-
associated changes in lung physiology increase susceptibility to and severity of both 
VILI and pulmonary edema independently during mechanical ventilation.  In the present 
study, we hypothesized that the negative synergy of the age-associated increases 
allows them to be powerful regulators of the age-associated increases in ventilator 
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mortality rates observed both in animal models and in older patients who are 
mechanically ventilated.   
In our 1hr ventilations we found significant increases in lung wet to dry 
ratiosventilator-associated with both advanced age and liberal fluid support.  These 
results support the general finding that age increases the incidence and severity of 
edema 59,94.  They also demonstrate our experimental model’s ability to induce 
ventilator-associated pulmonary edema with HVT mechanical ventilation and 
subsequently attenuate it through conservative fluid administration alone. 
Increased lavage protein concentration is a general marker of lung injury and of 
enhanced pulmonary permeability and edema98.  In our 4hr subjects, lavage protein 
concentration was significantly increased by HVT ventilation.  Importantly, old subjects 
on low fluid protocol exhibited near complete attenuation of the high protein containing 
BAL fluid produced by HVT ventilation.  As with our 1hr ventilation results, these data 
establish our ability to use HVT mechanical ventilation and conservative fluid 
management both induce and ablate pulmonary edema respectively.  
 Pulmonary disease changes the physiology of the lungs, which manifests as 
changes in respiratory mechanics. Therefore, measurement of respiratory mechanics 
allows a clinician to monitor closely the course of pulmonary disease99.  The area of the 
pressure volume loop (i.e., the hysteresis) is the geometric representation of the energy 
lost during each breath cycle.  Increased hysteresis is indicative of compromised lung 
mechanics function and is a hallmark of aging and various lung pathologies 25,100.  The 
one hour PV-Loop data demonstrated that conservative fluid support in the old HVT 
subjects attenuated age-related increase in MV induced pulmonary mechanical 
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disruption.  The success of these conservative fluid strategies in decreasing the severity 
of pulmonary edema and improving pulmonary mechanics in our 1Hr HVT subjects 
precipitated us to confidently apply our conservative fluid protocols to a group of old 
subjects being mechanically ventilated for 4hrs in hopes of increasing their survival rate.   
Predictably the four hour PV-Loop data showed an even more significant pattern of 
disruption and resolution of pulmonary mechanics with the administration of liberal and 
conservative fluid protocols respectively in our old murine subjects.  In young subjects 
we saw a similar pattern but none of hysteresis differences reached statistical 
significance.  
 In addition to their hysteresis values, the PV loops also contain information in the 
shape of their ascending limb.  In figure 22, we see that while the shapes of the PV 
loops of young LVT and HVT and old LVT subjects vary only minimally over time, the 
old HVT loops splay strongly to the left.  This represents an increasing rise in pulmonary 
compliance over time.  Increased lung compliance is a hallmark of the age-associated 
decline in lung mechanics and of many pathological conditions 53,58,101.  TLC is not 
considered to significantly change with age 102.  It is generally known that this effect 
results from the almost perfect balance between the age-associated increase in lung 
compliance, the decrease in respiratory muscle tone, and the increase in chest wall 
stiffness24.  However, in our experiments, the Flexivent system calculates TLC based 
upon the volume of air required to inflate the lung to a specified pressure.  Therefore, 
the age-associated loss of muscle tone does not affect the TLC measurements.  
Consequently, we expect the loss of lung compliance to dominate these measurements 
and expect to see TLC measurements taken with the Flexivent system to increase with 
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age.  Furthermore, certain types of lung injury (e.g., emphysema) increase lung 
compliance, and thus, they further increase total lung capacity as measured by our 
Flexivent system103. 
Both age and injury related increases in these pulmonary mechanical measures 
were observed in our study.  The significantly increased 0hr lung compliance and total 
lung capacity in old mice demonstrates the predicted age-associated changes in 
pulmonary physiology and mechanics.  The strong trend toward increased mean values 
of   both lung compliance and TLC observed in HVT vs LVT ventilator protocols seen in 
our older subjects therefore notable as well.  Even more striking is that both lung 
compliance and TLC values are significantly decreased in older HVT subjects when 
treated with conservative fluid protocols.  These findings demonstrate that HVT 
ventilation promotes greater injury compared to LVT ventilation in old animal subjects, 
and that this injury can be attenuated with a low fluid protocol alone.   
 Collectively these mechanics data paint a picture of an aging lung whose 
mechanical dysfunction is a downstream effect of the loss of elasticity and subsequent 
increase in compliance.  This is in agreement with the known age-associated decrease 
in elastin fibers of the lung parenchyma104.  However, it must be noted that in general 
having increased pulmonary edema classically decreases lung compliance.  This would 
seem to be in opposition to the pattern we observed of increasing lung compliance with 
injury.  However, VILI induced changes in the lung parenchyma do operate in the 
direction of increasing lung compliances.   In our histological analysis, we found a 
qualitative decrease in the presence and quality of elastin in older mice (Supplemental 
Figure).   
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 We further investigated our model’s effect on lung parenchyma destruction 
through measurement of ventilation-induced alveolar airspace enlargement.  Increased 
airspace enlargement values areventilator-associated with both increased age and 
pathophysiological conditions such as emphysema and VILI105,106.  In our case, the 
differences we observed in the airspace enlargement values for the experimental 
groups represent the extent of the alveolar barrier injury/destruction resulting from 
mechanical ventilation.  Just as with our mechanics, edema, and cytology data, we 
expected to observe a group-wise difference in the airspace enlargement values across 
age, with older mice exhibiting greater airspace enlargement values than younger mice.  
Further, we expected to see significant increases in airspace enlargement values of 
HVT subjects over non-ventilated controls and LVT subjects.   Our data not only 
showed both of these patterns, but additionally there was a significant interaction effect 
of increased airspace enlargement when advanced age combined with HVT ventilation.  
These pro-pulmonary compliance changes in the lung parenchyma work in opposition to 
the anti-compliant mechanics classically observed in an edematous lung.  The fact we 
seen an increasing compliance in our most injured subjects despite their increasingly 
edematous lungs suggests that the mechanical effect of the injury/destruction of the 
parenchyma has a more profound impact on the overall lung mechanics than the 
edema.  
 Our cytological analysis of BAL fluid demonstrates a pattern of inflammatory cell 
recruitment that further validates our experimental model of VILI in aging mice.  
Recruitment of lymphocytes, neutrophils, basophils, and eosinophils to the site of an 
injury is part of the normal immuno-inflammatory and wound healing response 40,107.  
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Literature, experimental data, and our research lead us to conclude that age-related 
increases in the severity of VILI should amplify this damage-associated pattern both 
systemically and in the microenvironment of the lung 57,59,90.  However, several studies 
have found little or no differences in BAL fluid cell count ratios between young and old 
healthy mice 96,103,108.  For this reason, we expected that we would only see significant 
differences in differential cell counts between ventilation control and HVT subjects and 
that furthermore; this pattern would be more exaggerated in the old vs. the young 
subjects. 
As expected, our cytological analysis failed to yield significant differences 
between young and old control groups.  The only significant differences we observed 
were between old subjects ventilated with HVT and young and old control groups.  
These cytology data support our hypothesis by demonstrating the synergistic effect of 
advanced age and HVT ventilation on lung inflammation and injury.  This age-
associated increase in ventilator –induced pulmonary “biotrauma” is decidedly “mid-
stream” in the VILI process.  Alveolar epithelial cell barrier function is known to be 
disrupted by inflammatory cytokines.  Increased pro-inflammatory cytokine levels in the 
lung promote disruption of the lung’s barrier function thus resulting in enhanced 
permeability and development of pulmonary edema.  
Thus, the work reported here demonstrates that a low fluid support strategy 
alone can reverse the age-associated increases in the 4hr hour mortality rate of older 
subjects ventilated with HVT.  The significantly important finding arising from this work is 
that development of pulmonary edema has both deleterious up and down stream 
   
69  
impacts on the development of VILI.  Further, we have identified the crucial role 
conservative fluid administration has in diminishing lung edema and the severity of VILI.   
In conclusion, our findings suggest that the age-associated increase in VILI-
induced pulmonary edema is not simply a downstream marker of injury but also a 
mechanism for further injury and increased mortality.  And while already known that 
conservative fluid support strategies give favorable outcomes to patients with ARDS, 
this is the first evidence that these strategies also attenuate VILI and its age-associated 
increase in severity.  Considering the relative lack of preventative treatments for VILI 
and the age-associated increases in injury and death, the development of age-
dependent fluid support strategies may be of critical importance in increasing the 
survival rate of elderly ventilator patients. 
 
2.5 Limitations 
The volume parameter of mechanical ventilations is generally determined by the 
application of a ratio between tidal volume and patient weight.  For this purpose it is 
often the preferred clinical practice to use a calculation of the patient’s ideal body weight 
instead of their actual weight as to not over or under ventilate under or overweight 
patients.  This is of particular importance in our study as 20 month old mice are reliably 
~30% more massive than their younger counterparts.  If not accounted for, this would 
result in the lungs of the older subjects being systematically inflated to larger volumes 
based on their size than those of their younger counterparts.  However, it has also been 
noted that while the lungs of the older mice may not be larger than those of the young 
adult mice, the increased mass of the older mice does correlate with an increased 
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circulatory volume.  Therefore while the weight-adjusted tidal volume may provide a 
lung volume normalized tidal volume, the older mice are receiving a lower tidal volume 
relative to their circulatory volume.  This is of course not different from how overweight 
human patients may be ventilated but is still a potentially important limitation to 
consider. 
 
3.0 
The Role of ER Stress and Aging in an In Vitro Models of Ventilator Induced Lung 
Injury 
3.1.0 Introduction 
Ventilator induced lung injury is initiated by mechanical insult to the lung.  However, it is 
the systemic release of cytokines that if unabated develops into systemic inflammatory 
response syndrome (SIRS).   SIRS in turn promotes multiple organ system dysfunction 
(MODS) which is the primary cause of death in VILI patients109.    
 The majority of patients requiring mechanical ventilation are over the age of 65 
and advanced age is known to increase the severity of VILI and in-hospital mortality 
rates29.  However, the mechanisms which predispose aging ventilator patients to 
increased severity of VILI and ventilator-associated mortality rates are not fully 
understood.  Age-associated pathological changes in lung mechanics are well known 
and have been implicated in the severity of VILI but the relationship has not yet been 
fully elucidated.  Additionally, the role of the aging alveolar epithelium in VILI is wholly 
unknown at this time.   
 There is however evidence to suggest that there may be a causal link between 
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epithelial cell aging and the age-associated increase in the severity of VILI.  In general, 
advanced age is also known to promote an increasingly dysregulated innate 
immune/inflammatory response to injury with an overall shift towards a proinflammatory 
state57,58.  Additionally, mechanical stretch alone has been shown to cause injury and 
promote a proinflammatory cascade in multiple cell lines40,110,111.  Mechanical stretch of 
lung epithelial cells has been shown to increase cell injury and death, increase 
apoptosis, increase acidification and bacterial growth, and increase general 
inflammatory response including gene expression and release of IL-6 and IL-8112. 
Additionally, mechanical stretch compromises epithelial barrier integrity by damaging 
the plasma membrane, increasing barrier permeability, and decreasing overall barrier 
function113–116.  
 Mechanical stretch has also been shown to increase oxidative stress and 
promote epithelial to mesenchymal transition in alveolar epithelial 113,114,117.  However, 
to date no research has been done to establish the effect of aging on mechanical 
stretch induced injury and inflammation in pulmonary epithelial cells.  Age alone is also 
known to increase inflammation and injury to various types of insult through the 
senescence-associated secretory phenotype (SASP) pathway118,119.  Aging has also 
been shown to promote chronic inflammation in the murine lung115.  Aging has also 
been shown to promote damage and inhibit repair in the lung epithelium following insult 
with influenza120.  We hypothesize that aged lung epithelia respond to mechanical 
stretch with a dysregulated inflammatory cytokine production which may be triggered by 
endoplasmic reticulum (ER) stress and the unfolded protein response (UPR).   
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 The endoplasmic reticulum is a multifunctional organelle responsible for lipid 
biosynthesis, calcium storage, and protein folding and processing64.  Because of the 
innate inefficiency of protein folding as many as 30% of proteins never acquire their fully 
folded conformation121.  The unfolded protein response (UPR) suppresses aggregation 
of these improperly folded proteins through three independent pathway which inhibiting 
protein synthesis, chaperone nascent or unfolded proteins, and discern then transport 
them through a degradation pathway before they can aggregate122.  However, if the 
UPR is unable to restore protein homeostasis inside the ER and resolve the 
aggregation of misfolded proteins, the apoptotic arms of the UPR is activated and 
apoptosis is accordingly promoted.  Thus prolonged unresolved ER stress can cause 
accumulation of misfolded proteins, disruption of cellular functions, apoptosis, and has 
been shown to play a key role in many chronic inflammatory disease states.  
Specifically in alveolar epithelial cells, ER stress has been shown to regulate apoptosis, 
idiopathic pulmonary fibrosis, and epithelial to mesenchymal transition123.  
 The UPR is also known to become increasingly dysregulated with age124.  There 
is a general age-associated increase in the occurrence of protein misfolding and 
accumulation.  There is also a downregulation of the three non-apoptotic arms of the 
UPR while the pro-apoptotic arm is semi-independently upregulated125,126.  
Unsurprisingly ER stress is implicated as a promoter of many pathological disease 
states associated with aging72.  Additionally, ER stress has been implicated in the age-
associated increase in pulmonary fibrosis127.  
 However, despite the clear path the VILI must take through systemic 
inflammation to claim MODS at its main cause of death, there have been no studies to 
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date of the role of ER stress in VILI.  Therefore unsurprisingly despite the well known 
the role of age-associated ER stress in many inflammatory disease states, VILI is not 
among them.    
To investigate this relationship we isolated and cultured primary alveolar epithelial ATII 
cells (ATIIs) from young and old murine subjects.  These cells were treated with 24h of 
cyclic mechanical stretch to promote mechanical stretch induced injury.  We measured 
age-associated differences in ER stress response, cell injury/inflammation, and 
apoptosis.  To help establish the position of ER stress relative to these measures of 
inflammation and injury in the VILI pathway we also inhibited ER stress using known ER 
stress inhibitor 4-phenylbutyrate (4-PBA)128.  4-PBA is already in use as a successful 
treatment for systemic inflammatory diseases such as diabetes129.  So in addition to 
determining location of ER stress in cellular inflammatory VILI cascade we are also 
evaluating a critically needed treatment for VILI in aging patients. 
 
3.2.0 Methods 
3.2.1 ATII cell isolation and culture:  For this project we harvested, isolated, and 
cultured ATII primary alveolar epithelial cells from young (8 week) and old (20 months) 
C57BL/6J wild type mice (WT) using previously cited methods [40].  Once cells were 
isolated we suspend them in Bronchial Epithelial Cell Growth Media (BEGM, Lonza) 
with all included supplemented added except hydrocortisone and supplemented with 10 
ng/ml KGF (keratinocyte growth factor, PeproTech).  Cells were then plated on collagen 
I coated 6-well silicone bottomed plates (Flexcell). 
3.2.2 ATII Cellular Phenotyping:  Cellular phenotyping was used to validate isolation 
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protocols.  48 hours after isolation both young and old cells were phenotyped using 
positive surfactant protein C (Abcam) primary antibody followed by AlexaFluor 488 
secondary and counter stained with prolong gold anti-fade reagent with DAPI nuclear 
stain.  A random sampling of images were qualitatively evaluated to pure ATII 
population in culture. 
3.2.3 CHOP Immunofluorescence:  Old and young mice were ventilated for 4 hours 
with ventilation protocol cited in chapter 2.  After 4 hour ventilation subjects were 
sacrificed, lungs were extracted and fixed, and serological lung sections were obtained 
using histology methods cited in chapter 2.  Slides were then stained with a primary 
antibody to CHOP (Cell Signaling, 1:1000) followed by AlexaFluor 594 secondary 
counter stained with DAPI nuclear stain, and imaged using an Olympus IX71 
Microscope (Olympus). 
3.2.4 Cell Stretch: After a 48 hour incubation we used the Flexcell Tension Plus 
System (Flexcell incto cyclically equibiaxially stretch the cells to and 15% change in 
surface area for durations of 4, 24, 48 and 96 hours.  This stretch percentage 
corresponds to the stretch seen by ATII cells during injurious MV.  Statically cultured 
ATII cells were used as controls.  After cells were stretch treated, we collected the 
media and mRNA from each well. 
3.2.5 ER Stress Inhibition:  One hour prior to mechanical stretch each well received 
either 100ul vehicle (phosphate buffered saline; PBS) or 10 mmol/L sodium 4-
phenylbultyrate (PBA) (Calbiochem, San Diego, CA) in 100ul PBS.   
3.2.6 MTT Assay:  MTT assays (Roche) were performed to measure net metabolic 
processing.  These results can be used to infer relative rates of cellular or cytostatic 
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activity. Decreases in MTT values represent increases in cell injury and/or death.   
Increases in MTT values indicate the shift of the ATII cells from a resting to proliferative 
state.   
3.2.7 mRNA Analysis: We collected mRNA from each treatment group (RNeasy Mini 
Kit, Qiagen), purified the mRNA and used a standard RT kit (Biorad) to convert the RNA 
to CDNA.  We used custom QPCR plates (Biorad) to perform QPCR analysis on 27 
inflammatory genes of interest (Aimp1, B2m, Ccl12, Ccl2, Ccl20, Ccl3,Ccl4, Ccl6, Ccl7, 
Ccl9, Ccr1, Csf1, Cxcl12, Cxcl15, Cxcl5, Gusb, HSP90ab1, Il10rb, Il15, Il1a, Il1r1, Il2rg, 
Il6st, Nampt, Sgpp1, Tnfrsf11b, Vegfa). 
3.2.8 Media Protein Concentration:  We performed BCA assays (Pierce) on all 
collected cell media samples to measure cell media protein concentrations.   
3.2.9 Inflammatory Mediator Analysis:  We measured the concentrations of select 
inflammatory cytokines of interest in the collected cell media of each experimental group 
using 10 protein (IL-1a, IL-1b, IL-4, IL-6, IL-10, IL-12, MCP-1, MIP-1a, RANTES, TNF-a) 
custom Bio-Plex ELISAs (BioRad).  Values were normalized to each samples protein 
concentration levels.  
 
3.3.0 Results 
3.3.1 Phenotyping: In both young and old ATII cells a random sampling of images 
confirmed positive staining for surfactant protein C (figure 27).     
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Figure 27: Representative 20X surfactant C images of A. Old 24Hr and B. Young 24Hr cells. Green are pro-SPC positive cells, blue are nuclei stained with DAPI 
Figure 28:  Representative 20X 4Hr histological CHOP images of A. Young LVT-HF, B. Old LVT-HF, C. Young HVT-HF, D. Old HVT-HF lung sections.  Yellow are CHOP positive cells, blue are nuclei stained with DAPI   
A B 
A B 
C D 
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3.3.2 CHOP Staining: Representative CHOP staining of lungs tissue displayed both a 
general age-associated and ventilator protocol associated difference in CHOP 
expression (figure 28).  Advanced age and HVT ventilation increased CHOP expression 
both independently and in combination.  
 
 
 
3.3.3 MTT Assay:  In Young 5% stretch groups 24Hr and 96Hr each had significantly 
higher MTT values than static controls.  In Young 15% stretch only 4Hr group had 
significantly higher MTT value than static control (figure 27A).  In Old 5% stretch groups 
only 96Hr group had significantly higher MTT value than static control.  In Old 15% 
stretch groups only 96Hr had significantly lower MTT value than static control (figure 
29B).  
3.3.4 Inflammatory Gene Expression: ER stress-associated Chop and ATF4 gene 
expression was significantly greater in Old 24Hr stretch ER control groups compared to 
every other group (figure 30).  No other relationships were significant.  However, Chop 
and ATF4 gene expression in Old 24Hr stretch ER Control group showed an increase in 
Figure 29: Normalized MTT absorbance values.  A. MTT values for Young 5% 24hr and 96hr groups were significantly higher than static controls.  MTT Value for Young 15% 4hr group was significantly higher than static control, B. MTT value for Old 5% 96hr group was significantly greater than static control.  MTT value for old 15% 96hr was significantly lower than static control. Data presented as mean +/- st.dev n=3 *p<0.05 
A B 
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mean compared to Old 24Hr static ER control.   Additionally, Chop and ATF4 gene 
expression in Old static ER inhibited groups showed a decrease in compared to Old 
24Hr static ER control but the trend was not significant.  
 
 
  
 
 
 
Advanced age alone and advanced age combined with mechanical stretch were 
associated with general increases in inflammatory gene expression (figure 31A).  
Figure 30: Age, stretch, and ER inhibitor induced inflammatory gene expression.  A,B. Old 24Hr Static ER Control, Old 24Hr Stretch ER Control, Old 24Hr Static ER Inhibited, Old 24Hr Stretch ER Inhibited, normalized to Old 24Hr Static ER Control.  Columns are fold change differences in gene expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05. 
A B 
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Figure 31: Age and stretch induced inflammatory gene expression.  A. Young 24Hr Static, Old 24Hr Static, Young 24Hr Stretch, Old 24Hr Stretch normalized to Young 24Hr Static.  B. Young 24Hr Static and Old 24Hr Static normalized to Young 24Hr Static.  Columns are fold change differences in gene expression. Data are presented as mean +/- st. deviation, n=3. 
 
A 
B 
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Advanced age alone significantly increased the gene expression of Ccl6, Ccl9, Ccr1, 
Il10rb, and Nambt in statically cultured old VS young cells (figure 31B and 32A).  
 
 
Figure 32: Age and stretch induced inflammatory gene expression.  A. Young 24Hr Static and Old 24Hr Static normalized to Young 24Hr Static.  B. Young 24Hr Static and Young 24Hr Stretch normalized to Young 24Hr Static.  Columns are fold change differences in gene expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05. 
A 
B 
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Mechanical stretch alone did not increase the expression of any inflammatory genes 
measured in young cell cells treated with 24Hr 15% stretch VS those statically cultured 
(figure gene 32B).        
 
 
Figure 33: Age and stretch induced inflammatory gene expression.  A,B. Old 24Hr Static and Old 24Hr Stretch normalized to Old 24Hr Static.  Columns are fold change differences in gene expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05. 
A 
B 
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Mechanical stretch alone increased gene expression of B2m, Ccl4, Csf1, and Il2rg in 
old cells treated with 24Hr 15% stretch VS old statically cultured cells (figure 33 A, B). 
   
  
   
Figure 34: Age and stretch induced inflammatory gene expression.  A,B. Young 24Hr Stretch and Old 24Hr Stretch normalized to Young 24Hr Stretch.  Columns are fold change differences in gene expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05. 
A 
B 
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Old cells treated with 24Hr 15% mechanical stretch had significantly increased 
expression of B2m, Ccl2, Ccl3, Ccl4 Ccl7, Ccl6, Ccl9, Ccsf1, Cxcl15, Il1a and Nampt 
compared to similarly treated young cells (figure 32A, B). 
 
 
 
 
Old cells stretched and treated with 4-PBA exhibited significantly decreased expression 
of B2m, Ccl6, Ccl7, Ccl9, Cxcl15, Nampt, Tnfrs11b and an increased expression of Il1a 
relative to old cells stretched and treated with sham ER inhibition (figure 35 A, B).  
Figure 35: Age and stretch induced inflammatory gene expression.  A,B. Old 24Hr Stretch ER Control and Old 24Hr Stretch ER Inhibited normalized to Old 24Hr Stretch ER Control.  Columns are fold change differences in gene expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05. 
A 
B 
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Treatment with 4-PBA significantly increased the expression of IL-1a and decreased 
expression of IL-6 in both old cells treated with 24Hr 15% stretch and those statically 
cultured (figure 36).   
 
 
 
 
3.3.5 Media protein concentration: Treatment with 4-PBA decreased the media 
concentrations of inflammatory cytokines IL-6, MIP-1b, MCP-1, and Rantes in both old 
cells treated with stretch and old statically cultured cells (figure 35 A,B,C,D). Treatment 
with 4-PBA increased the media concentrations of inflammatory cytokines proteins IL1a, 
IL-1b, IL-10 and MIP-1a in both old cells treated with stretch and old statically cultured 
cells (figure 37z E,F,G,H).   
  
Figure 36: Age and stretch induced inflammatory gene expression.  A,B. Old 24Hr Stretch ER Control and Old 24Hr Stretch ER Inhibited normalized to Old 24Hr Stretch ER Control.  Columns are fold change differences in gene expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05. 
A B 
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Figure 37: Cell media protein concentration.  A,B,C,D,E,F,G,H.  Old 24Hr Static ER Control, Old 24Hr Stretch ER Control, Old 24Hr Static ER Inhibited, Old 24Hr Stretch ER Inhibited.  Data are presented as mean +/- st. deviation, n=3, *p<0.05. 
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3.4.0 Discussion 
 Although the lung is undoubtedly one of the most physiologically complex organ 
systems, it is unique in that its operation can be almost completely automated through 
external stimulation long after the lung itself is too injured to function normally.  
However, like any other system in a profound state of injury the lung produces a 
predictable tirade of inflammatory cytokines27,41.  And the lungs vascularity and 
prominent position in the circulatory system guarantee that this inflammatory response 
is efficiently exported to all of the major organs systems of the body.   
 Therefore while mechanical ventilation has the ability to force the physiologically 
compromised lung to continue to oxygenate a patient’s body, in doing so the lung is 
transformed into a powerful inflammation exporting engine.  And because each other 
organ system has a maximum amount of inflammation it can tolerate before 
physiological failure, MODS rather than hypoxia is the leading cause of death 
associated with VILI130. 
 We know that systemic inflammation itself can lead to ARDS which is 
characterized by lung inflammation/injury, pulmonary edema, and compromised 
pulmonary mechanics.   Thus it is theoretically possible that mechanical ventilation itself 
is not innately injurious to the lung but rather the circulation of cytokines caused by pre-
existing lung pathologies could lead to systemic inflammation which in turn leads to a 
ventilator induced form of ARDS.  However, there are multiple experimental examples 
that demonstrate that systemic levels of cytokines in the circulatory system are 
increased by the ventilation of a previously uninjured lung even with “protective” 
ventilation protocols131–133.  This clearly establishes that mechanical forces alone and 
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the resultant deformations imparted to the lung during mechanical ventilation are 
sufficient to cause an inflammatory response independent of other factors.  This 
combined with the relatively straightforward nature of measuring, describing, and 
manipulating the mechanical forces associated with both spontaneous and mechanical 
ventilation has made modification of ventilation protocols the obvious initial target for the 
attenuation of VILI.   The two most common modifications to ventilation protocols 
associated with improved patient outcomes are decreased tidal volumes and the 
inclusion of PEEP in the ventilation cycle134.   
 However, despite the success of these kinds of protocols in attenuating VILI, 
mortality rates for ventilator patients is still extremely high.  The physiological pathway 
that leads these mechanical forces exerted on the lung to have MODS as their chief 
cause of death necessarily travels through cellular and inflammatory processes.  This 
means that it is critical to pursue cellular therapeutic targets for VILI as well.  Thus just 
as the known mechanical changes associated with the aging lung immediately suggest 
themselves as mechanism for increased susceptibility to VILI, an exploration of the MV 
to MODS inflammatory pathway does the same.  There is both a known increase in the 
inflammatory known age-associated increase in the upregulation of ER stress may 
further explain the age-associated increase in the severity of VILI and ventilator-
associated mortality rates.  
  Although there is a known increase in the severity of ER stress-associated 
with age, the underlying mechanisms are not known at this time.  To establish a link 
between this age-associated ER stress and ventilator induced lung injury in a murine 
model we began by staining lung sections from you young and old mechanically 
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ventilated murine subjects for CHOP.  A qualitative analysis of the alveolar CHOP 
expression confirmed an elevated level of ER stress-associated with both advanced age 
and HVT mechanical ventilation.   
  In order to confirm the role of this ER stress in the inflammatory VILI process we 
next isolated the effects of age and mechanical both independently and in combination 
on inflammation and injury.  We accomplished this by isolating, culturing, and 
mechanically stretching young and old ATII cells.  
 In statically cultured ATII cells we demonstrated that the there was a significant 
increase in the expression of Ccl6, Ccl9, Ccr1, Il10rb, and Nampt with age.  With the 
exception of Il10rb, each of these cytokines are associated with an increased level of 
inflammation in the lung which is not surprising owing to the known increase in systemic 
inflammation-associated with advanced age.  Ccr1 in particular is the receptor to Ccl3 
(MIP-1a) which is known to be upregulated in ventilator induced lung injury.  
Additionally, the blocking of Ccr1 has been shown to decrease lung damage and 
neutrophilic infiltration caused by high-pressure ventilation in vivo 135. 
 There was however no significant increase in expression of these or any other 
inflammatory genes we measured in our young mechanically stretched ATII groups 
compared to young static groups.  This is somewhat surprising.  But when considering 
the increase in proliferation associated with this group it is entirely possible that the 
proliferative signaling of 15% cell stretch is not significant to substantially activate pro 
inflammatory gene pathways in our ATII cells in a 24hr time frame.  Multiple studies 
have suggested that 15% stretch is insufficient to injure young alveolar epithelial 
cells113,116. 
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 The old AT2 cells were much more sensitive to mechanical stretch.  When 
compared to the gene expression of young cells stretched cells the old cells showed a 
significant increase in the expression of numerous inflammatory genes.  Not surprisingly 
they showed an increase in the expression of all of the inflammatory genes we saw 
previously upregulated with age alone.   
 However, there were a host of pro-inflammatory genes upregulated with only with 
the combination of age and stretch.  These genes are B2m, Ccl2, Ccl3, Ccl4, Ccl7, 
Cxcl15, IL1a, and IL6. B2m has long been recognized as a potential marker for 
inflammation, but its role in that process has yet to be elucidated.  Furthermore to date 
no specific role for B2m within the lungs has been established 136,137. This is important 
to note, because B2m is utilized in many models as a housekeeping gene.   
  Ccl2 is critical to leukocyte recruitment in the lung as well as being a regulator of 
numerous inflammatory disease states including ARDS, fibrosis, and cancer.  138–140 
As described previously, we demonstrated an age-associated increase in Ccr1 
indicating that the aging lung epithelium may already be primed to be more sensitive to 
Ccl3 which is itself upregulated by mechanical stretch in old ATII cells.  Ccl7 has been 
shown to be a strong regulator of neutrophilic lung inflammation.  Antibody 
neutralization of CCL2 and CCL7 significantly reduced LPS-induced total leukocyte and 
neutrophil accumulation in the lung alveolar lavage fluid of mice. 
 Ccl4 (MIP 1-b) is a macrophage inflammatory protein and is well established as a 
regulator in pulmonary inflammation in host of pathophysiological disease states of the 
lung141,142.  Cxcl15 is a neutrophil recruiting chemokine that is located in many mucosal 
organs including the gastrointestinal tracts, endocrine organs and adrenal glands.  
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Cxcl15 is expressed so abundantly in the lung however that it is known as lungkine.   
 IL-1a in an inflammatory cytokine that operates as an early necrosis alarmin and 
a juxtacrine signaling molecule143.  IL-1a release from damaged epithelial cells is both 
necessary and sufficient to trigger an inflammatory response in human lung 
fibroblasts.144  Additionally, IL-1a is an upstream regulator of the senescence associated 
secretory pathway and the release of IL-6 and IL-8143.  And lastly IL-6 is a pro-
inflammatory cytokine which is involved in a wide variety of inflammatory disease states 
including VILI 145 and was significantly upregulated in our old stretched cells. 
 To establish the mechanistic role of ER stress in these age-associated increases 
in mechanical stretch induced inflammatory gene expression we administered the ER 
stress inhibitor 4-PBA.  As stated previously the mechanism that increases the severity 
of ER stress with age are currently unknown.  However, we hypothesized that the 
molecular chaperone 4-PBA would still attenuate ER stress in our aged cell model. 
 Our gene expression results generally validate this hypothesis.  There were 
many inflammatory genes down regulated by the administration of 4-PBA.  Of particular 
interest are the genes B2m, Ccl7, Cxcl15, IL-6.  Each of these 4 inflammatory genes is 
known to contribute to pathological inflammatory processes in the lung, each was 
upregulated in the previous experiment with a combination of advanced age and 
stretch, and each was successfully downregulated with the administration of ER stress 
inhibitor 4-PBA alone.   
 Ccl6 and Ccl9 gene expression were both upregulated in old stretched cells VS 
static old cells as well.  And the gene expression of both were reduced with 4-PBA 
treatment.  However, since these were also both elevated in static old cells VS static 
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young cells their role in mechanical stretch induced inflammation is less clear.   
 Tnfrsf11b was also downregulated by 4-PBA but the meaning is also less than 
straightforward.  Tnfrsf11b is a decoy receptor for Nf-kb and is thought to mainly 
function as an inflammatory inhibitor.  It is also known to play an important role in 
inhibiting oseoclastogenesis but it’s role in the lung epithelium is unknown to date146.  It 
is possible that is this gene is activated to attenuate inflammation then a 4-PBA induced 
reduction in inflammation may have reduced upstream activation of Tnfrsf11b gene 
expression.  
 Lastly and most puzzlingly, there was a 4-PBA induced increase in IL-1a 
expression.  IL-1a is known only as an inflammatory cytokine and has no known anti-
inflammatory roles that would suggest a reason why it and it alone would be 
upregulated in old stretched cells treated with 4-PBA.   
 To further establish the translatability of these results into a novel in vivo target 
for treatment of VILI we investigated the 4-PBA induced changes in concentrations of 
inflammatory cytokines secreted into the cell media.  These results revealed the 
inhibition of the secretion of several different inflammatory cytokines.  Furthermore the 
patterns of changes are generally in good agreement with the with the corresponding 
changes 4-PBA induced changes in gene expression.   
 IL-6, Ccl2 (MCP-1), Cc-l4 (MIP-1b), and RANTES media concentrations were all 
significantly decreased with ER inhibition in both stretched and statically cultured ATII 
cells.  Of these RANTES is the only one not already discussed thus far.  RANTES is 
pro-inflammatory neutrophil recruiter implicated in multiple pathological pulmonary 
inflammatory conditions including pulmonary fibrosis, lung cancer, and viral lung 
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infections147–149.   4-PBA upregulated IL-10 media concentration in both stretched and 
static old cells.  IL-10 has a somewhat complex role in the pulmonary has an 
inflammatory process but is primarily anti-inflammatory supporting results of the 4-PBA 
as attenuating ER stress  
 Additionally, 4-PBA treatment upregulated media concentrations of both IL-1a 
and IL-1b in stretched and statically cultured old cells.  This result is internally consistent 
with our findings regarding the upregulation of IL-1a and IL-1r1 gene expression.  It 
confirms that these gene expression results are not just anomalous gene results but 
rather translate into a meaningful difference in the cytokine excretion into the cell media.  
The meaning of this effect and how to integrate it with known inflammatory physiology is 
however unclear.  
 And lastly, the media concentration of Ccl3 (MIP1a) is strongly upregulated in 
media samples of both stretch and static old cells treated with 4-PBA.  This result is 
difficult to contextualize for two reasons.  Firstly, this is the only protein secretion result 
that seems to be at odds with our gene expression data.  While 4-PBA decreased the 
Ccl3 gene expression, it seems to have increased the secretion of Ccl3 cells into the 
surrounding media.  Additionally, there is not an easily forthcoming explanation based 
on our current understanding of MIP-1a and MIP-1b for why there would be any single 
chemical chaperone what would have the effect of simultaneously and promoting and 
attenuating the excretions of these two cytokines respectively.   
 In summation with the exception of Ccl3 of effects of 4-PBA treatments on cell 
media cytokine concentrations are in good agreement with the gene expression data.  
And with the exception of an upregulation of IL-1a the gene expression data is in good 
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agreement with our hypothesis that 4-PBA successfully attenuates the age-associated 
stretch induced increase in inflammatory gene expression.    
 
4.0.0 
VitC treatment attenuates VILI induced pulmonary edema and partially normalized 
pulmonary mechanics.  
4.1.0 Introduction 
The pulmonary system is unique in its design in that each incremental step towards its 
most distal region sees a meaningful increase in the complexity of the mechanical, 
molecular, and physiological environment7,24.  This organizational facet of the 
pulmonary systems owes in part to the exponential manner in which succeeding 
generations decrease in size terminating with the alveolar sacs having a structure in the 
micrometer range.  Furthermore the contribution to the lungs primary function of gas 
exchange exhibit a parallel asymmetry with the alveolar sacs hosting of 90% of all gas 
exchange.  Thus the alveolar barrier is at once one of the most complex, biologically 
essential, difficult to observe, and consequently least well understood regions of the 
body.  Not surprisingly many pathophysiological conditions of the alveolar barrier are 
poor elucidated as well.   
Furthermore the molecular pathophysiological effects of aging have only begun 
to be recognized and thoroughly studied relatively recently.  Thus the effects of aging on 
alveolar barrier function are at a time both of such critical importance and so 
understudied that the American journal of physiology has put out a call for studies on 
this topic.  Since then there have been some studies conducted to establish the 
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pathophysiology of senescent alveolar cell types and the aging extra cellular network 
but few studies address the effect of aging on alveolar barrier integrity directly.  In 
addition to our investigation of the aging lung and its interaction with VILI, in this project 
we are involved in an ongoing investigation of VitC as a possible treatment for VILI and 
other lung pathologies.   
VitC is an essential nutrient for humans and many other animal species which 
means that prolonged VitC deficiency results in a myriad of serious health complications 
and eventually results in death150.  VitC has a number of vitamers including its reduced 
form ascorbic acid (AscA) and its anion ascorbate151.  Most animals that require VitC 
are able to fully meet their requirements by synthesizing VitC from glucose.  Humans 
and other primates however cannot synthesize VitC as a result of a loss of function in 
the gene for the enzyme L-gulono-gamma-lactone oxidase (Gulo) which is required in 
the terminal step of ascorbate synthesis.  By contrast, mice and rats produce 
endogenous VitC and maintain high levels of ascorbate in their tissues.  This 
complicates the translatability of VitC studies from mice and rats to humans.  To 
overcome this limitation C57BL/6J wild type mice (WT) with a homozygous knockout of 
the crucial Gulo producing gene (gulo-/- mice) are often employed for VitC research152.  
Additionally, (WT) mice with a knockout of senescence marker protein-30 (SMP30) are 
unable to synthesize VitC and are useful for VitC research as well153.   
VitC has many known biological functions all of which originate from its chemical 
activities as a 1- or 2-electron reducing agent for several antioxidants 151.  Specialized 
cells throughout body can take up AscA through Na+-dependent ascorbate 
cotransporters (SVCT1 and SVCT2). Most other cells take up VitC in its oxidized form 
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(DHA) via facilitative glucose transporters154.  VitC is also a known cofactor in at least 8 
enzymatic reactions 7 of which are collagen synthesis reactions.  As a result VitC’s 
corresponding avitaminosis, scurvy, is characterized by a generally increase in 
sensitivity to oxidative stress.  Additionally, over time VitC deficiency promotes 
malformation of collagen in many of the bodies tissues including the skin, gums, 
cartilage, blood vessel walls, and lung parenchyma150.  These malformations can lead 
to bruising, bleeding, and inhibited wound healing in all of these tissues.  
In addition to the generalized effects, VitC deficiency is known to have multiple 
pathogenic effects on the lung.  VitC deficient gulo-/- mice have been experimentally 
shown to have an increased lung pathology following infection with influenza155.  One 
study also showed that by their third month of life VitC deficient SMP 30 knockout mice 
showed an 82.2% decrease in collagen I mRNA and the development of emphysema 
(21.6% increase of mean linear intercepts (MLI) and 42.7% increase of destructive 
index measured as described by Koike et al156). 
VitC levels have been shown to decrease with age in both humans and in 
animals who make their own VitC.  An analysis of the ascorbic acid levels in the hepatic 
cells of 24-26 month old rats showed a 68% decrease from the levels seen in 3-5 month 
old rats157.  Similarly in humans it has been known for several decades that serum 
levels of VitC decrease with age.  A meta-analysis of 30 publications showed a 
significantly lower serum plasma VitC level older adults (aged 60-96) than in younger 
adults (aged 15-65) with similar VitC intake156.  The exact reason for this disparity is not 
yet known however one study demonstrated that in older rats there was a 45% 
decrease in the mRNA levels of one of the isoforms of the sodium dependent VitC 
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transporter (SVCT1)157.  Furthermore there are multiple studies which suggest that the 
decrease in VitC associated with aging promote the development of chronic obstructive 
pulmonary disease158,159.  All of this research suggests that elderly people have both 
higher VitC requirements than the young and a greater susceptibility to lung and injury 
are related illnesses because of decreased VitC levels. 
There are also experiments that demonstrate that levels of VitC that far exceed 
those found in human and murine plasma and tissues can have a therapeutic effect.  In 
one experiment fibroblasts derived from human skin biopsies were cultured separated in 
groups that were passaged 5, 10, 15, 20, 25 or 30 times respectively160.  Cells that were 
passage 20 or more times showed a significant loss of all enzyme activities.  The 
addition of ascorbate to the cell media equivalent to that of normal human plasma 
concentrations (100 µmol 1−1) had no effect on the enzyme activities of the fibroblasts.  
The addition of 300 µmol 1−1 ascorbate however totally restored Complex II-IV and 
citrate synthase activities and partially restored the activity of Complexes I-III. 
VitC has also been shown recently to be a powerful regulator of sepsis across 
several experimental models and of sepsis induced ALI.  Sepsis is a leading cause of 
death in the United States and is the most common cause of death among critically ill 
patients outside of coronary intensive care units161.  The respiratory tract is the most 
common site of septicemic infection and is associated with the highest 
mortality.   Patients who develop severe sepsis have a 25% in hospital mortality rate 
which jumps to 50% in the case of septic shock.  The incidence of severe sepsis in the 
United States is estimated to be 300 cases per 100,000 population and septicemia 
related hospital costs are estimated at $14 annually.  MODS is the leading cause of 
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death in sepsis patients and consequently the number of organs failing and the degree 
of organ dysfunction is the leading predictor pf patient mortality109.  Additionally, 
septicemia incidence and septicemia-related deaths have increased over the past 2 
decades in United States. 
 It is also known that a significant percentage of patients with severe sepsis 
develop acute lung injury (ALI)162.  Thus inducing sepsis is frequently used in in vivo 
animal models to experimentally induce ALI.  Sepsis is known to compromise alveolar 
barrier integrity in a number of ways stemming from its associated systemic pro 
inflammatory responses and the degradation of endothelial tight cell junctions163.  The 
immune inflammatory response to the initial onset of sepsis is activation and tissue 
infiltration of polymorphonuclear neutrophils PMNs.   In the microenvironment of the 
alveolus PMNs upregulate inflammation, increase the permeability of microvascular 
barriers, and promote in extravascular accumulation of protein-rich edema fluid.  
Alveolar infiltration of PMN is a hallmark of ALI and is known to be a primary 
mechanism for sepsis-induced pulmonary dysfunction and injury154,164,165.   
 This PMN infiltration and the general inflammatory pathway that lead sepsis to 
promote ALI is strongly regulated by NFkB.  NFkB is proinflammatory transcription 
factor that plays a key role in host defense, inflammation, and apoptosis164,165.  NFkB is 
activated by proinflammatory cytokine induced phosphorylation and degradation of 
inhibitor kB proteins.  And TNFa induced NFkB activation has been shown to be 
inhabitable with VitC in multiple studies and over multiple cell population.  
Sepsis is also associated with a profound systemic oxidative stress which not 
surprisingly has been demonstrated to severely lower antioxidant level in patient plasma 
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including AscA.  Therefore not surprisingly low levels of AscA correlate with multiple 
organ system failure and inversely with patient survival154.  It has also already been 
shown experimentally that in VitC deficient animal models of sepsis that parenteral 
ascorbate attenuates the effects of sepsis154,166.  Experiments have also shown that in 
WT mice administered parenteral VitC treatments have a strong therapeutic effect on 
sepsis induced ALI.   
Sepsis is modeled in a variety of ways in vivo.  Endotoxin, a component of the 
outer membrane of Gram-negative bacteria, is involved in the pathogenesis of sepsis, 
and an LPS infusion/injection model has been widely used for sepsis research. LPS 
administration induces systemic inflammation that mimics many of the initial clinical 
features of sepsis, including increases in proinflammatory cytokines such as TNF-α and 
IL-1, but without bacteremia167. 
 Sepsis also has a powerful interaction with patient age.  Sepsis is the tenth 
leading cause of death in patients over the age of 65 in the US since.  Advanced aged 
patients also account for 58–65% of all sepsis patients.  Additionally, both the incidence 
and mortality rates of sepsis patients increase significantly with advanced age168   
Owing to the fact that inhibition of LPS induced NFkB activation had not yet been 
investigated, our collaborators conducted an in vivo study of VitC treatment on LPS 
induced sepsis and ALI.  ALI was induced in WT mice with an injection of a lethal 
lipopolysaccharide (LPS) dose (10 ug/g of body weight).  30 minutes after the LPS 
injection mice either received an intraperitoneal (i.p.) injection of 200 mg/kg AscA, the 
oxidized form of AscA (DHA) at 200 mg/kg, or saline.  There was a 100% mortality after 
28 hours for mice receiving saline.  In contrast there was a 60% survival for mice 
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receiving AscA and a 75% survival rate for mice receiving DHA even after 72 hours.  In 
addition compared to saline controls, WT mice treated with AscA/DHA had suppressed 
inflammatory chemokine expression, decreased microvascular thrombosis in the lungs, 
suppressed proinflammatory gene expression, and attenuated neutrophilic capillaritis 
and vascular leak in the lungs. 
Another common method for modeling sepsis is through injection of fecal solution 
known as fecal-induced peritonitis (FIP).  Conventional animal models of sepsis are 
typically microbial-based responses which may be mono- or poly-microbial in design. 
Using a single organism results in a septic state that is dependent on the type and 
amount used as well as the animal and route of administration, whereas a polymicrobial 
model typically mimics intra-abdominal sepsis, which affects 20% of patients admitted 
with sepsis. Polymicrobial models of sepsis typically involve either FIP or cecal ligation 
and puncture (CLP).  In the FIP model, a freshly prepared fecal solution is derived from 
murine colonic stool and injected intraperitoneally into mice at a defined concentration 
to result in acute peritonitis163,169. 
 Additionally, the same research group performed experiments directly tested the 
effects of VitC deficiency on sepsis induced ALI in mice with and without VitC treatment.  
Sepsis was induced with an i.p. injection of fecal stem solution which induced peritonitis 
(FIP).  They showed that the pathogenic effects of sepsis induced ALI were strongly 
attenuated in VitC sufficient gulo-/- mice (gulo-/- supplemented with dietary VitC) and in 
VitC deficient gulo-/- mice treated 30 minutes after FIP exposure with 200 mg/kg AscA 
compared to their VitC deficient gulo-/- counterparts that received only saline treatment.  
Gulo-/- mice who had either VitC supplementation or VitC treatment had less 
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proinflammatory response in the lung, greater capillary barrier function in the lung, less 
lung water accumulation, and better preservation of their lung architecture than mice 
without any VitC treatment and the mice with both VitC supplementation and VitC 
treatment had the greatest attenuation of sepsis induced ALI154.   
 In addition to its usefulness in experimentally inducing ALI, sepsis bears a close 
resemblance to the disease process of VILI.  Experiments employing gene array 
methodology to measure lung gene expression have identified differential patterns of 
gene expression in animal models of VILI which are similar to those gene pathways 
activated during experimental and clinical sepsis170,171.  All of this has lead our group to 
hypothesize that VitC treatments would confer a protective effect against ventilator 
induced lung injury to our older mouse subjects.  
Just as with LPS induced ALI, we hypothesize that VitC treatment’s down 
regulation of NFkB, decrease of alveolar barrier permeability, and restoration of alveolar 
barrier integrity will attenuate VILI induced edema in our aged mice.  And based on the 
wide spread protective effect that our novel low fluid protocol conferred we hypothesis 
that VitC attenuation of edema will decrease injury and inflammation, improve 
pulmonary mechanics, and increase subject survival.   To test this hypothesis we 
ventilated old mice old mice each either receiving VitC treatment or sham.  During 
ventilation we measured pulmonary mechanics.  After ventilation treatments each 
mouse was sacrificed and lung we to dry ratios were measured.  
 
4.2.0 Methods 
   
101  
4.2.1 Animal Use:  This study was approved by the VCU Institutional Animal Care and 
Use Committee (protocol number AD10000465).  Male C57BL6 mice were used in 
these experiments.  All animal experiments were carried out under IACUC University 
guidelines.  
4.2.2 Age Groups:  Old animals, 20-22 months of age, weighing 35 ± 11 g.  Ages of 
our murine subjects were based on correlations between murine lifespan and known 
age-associated morphological changes in murine lung (17)(29).  
4.2.3 Mechanical Ventilation:  20 month old Murine subjects were anesthetized and 
mechanically ventilated for 1 hour using the same protocols outlined in chapter 2 
methods section.   
4.2.4 VitC Treatment:  Each VitC treatment mouse received an IP injection of 200 
mg/kg AscA in 100ul saline immediately prior to ventilation.  Control mice received a 
VitC sham IP injection of 100ul saline just prior to ventilation.   
4.2.5 Pulmonary Mechanics:  Pulmonary mechanics measurements were taken for 
each subject at the 0hr and 1hr time points using the same protocol described in 
chapter 2 methods. 
4.2.6 Lung Wet to Dry Rations:  After 1hr each subject was sacrificed, its lungs were 
removed, and wet to dry ratios were collected using methods described in chapter 2 
methods. 
4.2.7 Data Analysis:  Data analysis was performed on the pulmonary mechanics and 
wet to dry ratio data using the same methods outlined in the chapter two methods 
section.  
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4.3.0 Results 
4.3.1 One Hour Lung Wet to Dry Ratios:  Wet to dry ratios for each of the old 1hr 
groups (figure 38). The wet to dry ratios for HVT high fluid subjects receiving VitC 
protocol was significantly lower than that observed in all other old groups (figure 38).  
The wet to dry ratio of old HVT subjects receiving low fluid protocol was significantly 
lower than that observed in the old HVT subjects who received high fluid protocol and 
the old non-ventilated group (figure 38).   
 
4.3.2 PV Loop Hysteresis:  PV loops were generated hourly using the Flexivent 
software (Scireq) for each surviving subject. Representative PV loops shown in figure 
39. The hysteresis values of each group were normalized with respective 0hr values 
(figure 39).  1Hr PV loop hysteresis of Old HVT high fluid group was significantly greater 
than that of the Old HVT low fluid and Old HTV high fluid VitC group (figure 39).     
Figure 38: 1Hr Lung Wet to Dry Ratios.  The Old HVT-HF-LF and Old HVT-HF-VitC groups were significantly lower than that of Old non-ventilated and Old HVT-HF groups.  Data are presented as mean +/- st.dev N = 3, *p<0.05  
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 Figure 39: 1Hr PV Loop Hysteresis. Hysteresis in the Old HVT-LF and Old HVT-HF-VitC group were significantly greater than Old HVT HF. Data are presented as mean +/- st.dev N=3, *p<0.05 
 
 
4.3.3 Lung Compliance:  Lung compliance was measured hourly using the Flexivent 
software (Scireq) for each surviving animal subject (figure 40).  The 1Hr lung 
compliance of the old HVT high fluid group was significantly greater than that of the 
HVT low fluid group.  There was a strong non-significant trend with the old 14Hr HVT 
high fluid VitC group having a lower mean than the old 4Hr high fluid group that fell just 
Figure 40: 1Hr Lung Compliance. Lung Compliance in the Old HVT-LF group was significantly lower than Old HVT-HF. Data are presented as mean +/- st.dev N=3, *p<0.05    
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short of significance.  This HTC VitC has no significant differences with the HTV-LF 
values with a one way anova P-value of .08.  However, due to the need to exclude one 
data outlier the groups has an N value of only N= 2.  We suspect this relationship will 
become significant with additional subjects.     
 
4.4.0 Discussion 
The only ventilation mechanics statistic that was collected but yielded no significance 
was the measurement of inspiratory capacity.  The low fluid treatment was able to 
create a treatment based difference in the inspiratory capacity but it is possible that one 
hour is simply insufficient for the VitC treatments to remodel this aspect of the 
pulmonary mechanics.   
 The success of these early results is highly promising and offers a potentially 
powerful therapeutic option for patients requiring mechanical ventilation.  Considering 
the natural decrease in VitC levels associated with age and the corresponding increase 
in the severity of VILI seen with increasing patient age this development of age based 
VitC treatments protocols for patients requiring mechanical ventilation may be critically 
important for ensuring the health and wellbeing of elderly patients.    
 
5.0.0 
Implications of completed work 
Close to a million patients in the US require mechanical ventilation annually.  Knowing 
that proper mechanical ventilation can literally mean the difference between life and 
death for many of these patients means that the importance of mechanical ventilation 
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cannot be overstated.  Additionally, for a patient population this large, a 30% in hospital 
mortality rate is devastating. However, the historical perspective on this mortality rate is 
very elucidating as well.  As recently as the 1970’s the in hospital mortality rate of 
patients with severe ARDS was 90%172.  And there are still particularly vulnerable 
patient populations today.  For example patients requiring MV as a result of ischemic 
stroke have a short term mortality rate of 50-90%173.  In fact many of the most common 
comorbidities with mechanical ventilation (ARDS, Phenomena, COPD, etc.) are known 
to increase ventilator-associated mortality rates.   
 This reinforces the urgency with which we must not only drive down the overall 
ventilator-associated patient mortality rates, but also identify populations particularly 
sensitive to VILI and tailor specific treatments for them.  Demographically the largest 
sub population of ventilator patients with a significantly increased risk of mortality is the 
elderly.  In fact, patients over the age of 65 represent over half of all mechanically 
ventilated patients.  Furthermore the aging population in the US is poised to 
precipitously grow over the next few decades174 which will only see an increases in the 
urgency with which we must address this issue.  While some of the mechanical changes 
of the lung associated with aging have been studied and understood for the better part 
of the last century, aging on the cellular level has only recently been studied.   
 Our initial four hour injurious mechanical ventilation protocol, while readily 
survivable by young mice, proved to be too challenging for our older subjects with very 
few surviving.  In searching for protocol modifications that would aid elderly subject 
survival we discovered a recent research consensus and resultant recommendation 
from ARDSNet concerning the protective effects of fluid restriction.  Critically ill ARDS 
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patients with conservative fluid management had consistently better outcomes than 
those treated with liberal fluid protocols.  We hypothesized that a conservative fluid 
protocol might confer protection to our aging VILI subjects as well.   
 Despite our hypothesis, our level of success at increasing the survival of our 
older subjects by simply changing their fluid treatment protocol was more dramatic than 
we had originally anticipated.  A careful examination of the presence of pulmonary 
edema as well as other markers of inflammation and injury clearly indicated that our 
conservative fluid protocol alone was capable modulating VILI-associated edema.  
Furthermore it established that resolution of this edema has a strong protective effect on 
other downstream ventilator induced injuries. 
 Pulmonary edema is well established as a hallmark of VILI and is considered to 
be a downstream inevitability of the type lung damage and inflammation there in.  What 
is so unique about this research is its establishment that pulmonary edema is actually 
upstream of much of the injury and inflammation associated and VILI and that the 
resolution of edema alone can dramatically increase the survival of elderly murine 
subjects.   
 The implication of the research for elderly ventilator patients is both dramatic and 
immediate.  However, just as with all biomedical challenges it is important to pursue 
multiple vectors of attack.  Identifying pulmonary edema as a target in the age-
associated increase in ventilator-associated mortality opens the door for us to both seek 
a more mechanistic explanation of these underlying processes and to pursue additional 
treatment targets.   
 Moving forward, we had to attempt to answer the question as to why the lungs of 
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our young subjects were so readily able clear or even avoid the accumulation addition17 
al of alveolar fluid load but this challenge proved fatal for our older subjects.  The 
answer to this question begins with the fulfilment of our second specific aim.  Our 
understanding of the aging lung epithelium as a physiological unit is radically 
underdeveloped.  Currently there are no major physiological mechanisms of the aging 
alveolar epithelium itself that have been identified as major contributors to VILI. 
 Inflammation itself however, especially the presence of inflammatory cytokines, is 
known to severely compromise epithelial barrier integrity and in the micro environment 
of the lung strongly promoted edema.  Furthermore there has been a recent explosion 
in the understanding of the role of biotrauma as a mechanism of VILI.  Furthermore, ER 
stress is known to play a key role in many organ systems and pathological disease 
states to promote age associate increases in inflammation.  We hypothesized that ER 
stress was likely a key player in the age-associated increase in VILI as well.   
 Knowing that stretch induced inflammation and injury can be achieved in cultured 
primary alveolar epithelial cells, we hypothesized that cells harvested from old mice 
would be significantly more injured/inflamed than young.  Furthermore if our hypotheses 
were correct, we would be able to attenuate this age-associated increase in 
inflammation with the administration of an ER stress inhibitor.  Our success at achieving 
this result validates out hypothesis and establishes the importance of ER stress in the 
age-associated increase in alveolar epithelial inflammatory response to mechanical 
stretch.  To establish the effect of this relationship on the development VILI-associated 
edema in vivo experiments are clearly needed and represent an obvious avenue for 
future research.   
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 The success of both of our first aims direct us to further expand our search for 
treatments that might further fortify the alveolar epithelial barrier against insult and 
injury.  Our first aim identifies pulmonary edema as an important mechanism for the 
age-associated increase VILI mortality rates in our subjects.  Inflammation is known to 
be a powerful promoter of alveolar edema and the completion of our second aim offers 
a possible age-associated inflammatory mechanism driving our VILI-associated edema.  
So an ideal preventative treatment for VILI would be one that was profoundly anti-
inflammatory, was known to decrease alveolar permeability, and had already been 
proven to dramatically decrease pulmonary edema.  VitC is well knows to be anti-
inflammatory, to decrease alveolar membrane permeability, and VitC treatments have 
been shown to aide in the resolution of pulmonary edema.  Additionally, VitC has 
already been shown to have a dramatic effect on both ARDS and Sepsis.  This is also 
particular value in a potential VILI treatment owing to the fact that these diseases more 
than any others either mimic or are direct pro/antecedent to VILI.  
 We naturally hypothesized that VitC would confer a protective effect to our older 
murine subjects and attenuate their VILI-associated edema and the downstream 
injurious effects.  Our pilot study confirmed just this by showing a dramatic decrease in 
the wet to dry ratios of old subjects treated with VitC prior to HVT mechanical 
ventilation.  Furthermore, impaired pulmonary mechanics which were identified in our 
first project to be a downstream effect of VILI-associated edema were attenuated as 
well.  These preliminary results provide a strong proof of concept that VitC treatments 
can attenuate the age-associated increase in VILI-associated edema.  The next 
experimental step is clearly outlined and will consist of a repeating our previous survival 
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study with the addition of VitC treated subjects. 
 Each of these aims contributes indispensably to the picture of how the aging lung 
interacts with VILI.  The repositioning of pulmonary edema as a “mid-stream” 
mechanism in VILI for the first time opens up anti-edema measures as a powerful 
protective therapeutic target.  Additionally, the identification of ER stress as a 
regulatable source of age-associated stretch induced alveolar epithelial inflammation 
makes the ER an invaluable target for attenuating age-associated pulmonary edema.  
And finally the success that VitC has already enjoyed as a treatment for ARDS and 
sepsis in mice combined without our pilot data demonstrating its ability to attenuate 
VILI-associated edema starkly confirm the need for its pursuance as a preventative 
treatment for VILI. 
 Our sincerest hope is that all three of these experimental avenues both 
independently and in consort will push forward the development of much needed 
lifesaving age dependent ventilator protocols in clinic.  
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